<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus - Colunga‐Lozano, LE - 2018 | Cochrane Library</title> <meta content="Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus - Colunga‐Lozano, LE - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011296.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus - Colunga‐Lozano, LE - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011296.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011296.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus" name="citation_title"/> <meta content="Luis Enrique Colunga‐Lozano" name="citation_author"/> <meta content="McMaster University" name="citation_author_institution"/> <meta content="dr.colunga.lozano@gmail.com" name="citation_author_email"/> <meta content="Franscisco Javier Gonzalez Torres" name="citation_author"/> <meta content='Hospital Civil de Guadalajara "Dr. Juan I Menchaca"' name="citation_author_institution"/> <meta content="Netzahualpilli Delgado‐Figueroa" name="citation_author"/> <meta content="Hospital Civil de Guadalajara Dr. Juan I. Menchaca" name="citation_author_institution"/> <meta content="Daniel A Gonzalez‐Padilla" name="citation_author"/> <meta content="Hospital Universitario 12 de Octubre" name="citation_author_institution"/> <meta content="Adrian V Hernandez" name="citation_author"/> <meta content="University of Connecticut" name="citation_author_institution"/> <meta content="Yuani Roman" name="citation_author"/> <meta content="Institute of Biomedical Research Sant Pau (IIB Sant Pau), Barcelona" name="citation_author_institution"/> <meta content="Carlos A Cuello‐García" name="citation_author"/> <meta content="McMaster University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD011296.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/11/29" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011296.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011296.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011296.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Inpatients; Cause of Death; Diabetes Mellitus, Type 2 [*drug therapy, mortality]; Hypoglycemia [chemically induced]; Hypoglycemic Agents [*administration &amp; dosage, adverse effects]; Insulin [*administration &amp; dosage, adverse effects]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011296.pub2&amp;doi=10.1002/14651858.CD011296.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="jxlIh5Me";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011296\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011296\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","de","ms","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011296.pub2",title:"Sliding scale insulin for non\\u2010critically ill hospitalised adults with diabetes mellitus",firstPublishedDate:"Nov 29, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Metabolic and Endocrine Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011296.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011296.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011296.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011296.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011296.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011296.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011296.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011296.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011296.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011296.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>14553 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011296.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/full#CD011296-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/full#CD011296-sec-0117"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/full#CD011296-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/full#CD011296-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/full#CD011296-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/full#CD011296-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/full#CD011296-sec-0073"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/full#CD011296-sec-0111"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/appendices#CD011296-sec-0122"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/table_n/CD011296StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/table_n/CD011296StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/information#CD011296-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Luis Enrique Colunga‐Lozano</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/information#CD011296-cr-0003">Franscisco Javier Gonzalez Torres</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/information#CD011296-cr-0004">Netzahualpilli Delgado‐Figueroa</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/information#CD011296-cr-0005">Daniel A Gonzalez‐Padilla</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/information#CD011296-cr-0006">Adrian V Hernandez</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/information#CD011296-cr-0007">Yuani Roman</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011296.pub2/information#CD011296-cr-0008">Carlos A Cuello‐García</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/information/en#CD011296-sec-0138">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 29 November 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011296.pub2">https://doi.org/10.1002/14651858.CD011296.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011296-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011296-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011296-abs-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011296-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011296-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011296-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011296-abs-0001" lang="en"> <section id="CD011296-sec-0001"> <h3 class="title" id="CD011296-sec-0001">Background</h3> <p>Diabetes mellitus is a metabolic disorder resulting from a defect in insulin secretion, function, or both. Hyperglycaemia in non‐critically ill hospitalised people is associated with poor clinical outcomes (infections, prolonged hospital stay, poor wound healing, higher morbidity and mortality). In the hospital setting people diagnosed with diabetes receive insulin therapy as part of their treatment in order to achieve metabolic control. However, insulin therapy can be provided by different strategies (sliding scale insulin (SSI), basal‐bolus insulin, and other modalities). Sliding scale insulin is currently the most commonly used method, however there is uncertainty about which strategy provides the best patient outcomes. </p> </section> <section id="CD011296-sec-0002"> <h3 class="title" id="CD011296-sec-0002">Objectives</h3> <p>To assess the effects of SSI for non‐critically ill hospitalised adults with diabetes mellitus. </p> </section> <section id="CD011296-sec-0003"> <h3 class="title" id="CD011296-sec-0003">Search methods</h3> <p>We identified eligible trials by searching MEDLINE, Embase, LILACS, and the Cochrane Library. We searched the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) and ClinicalTrials.gov trial registers. The date of the last search for all databases was December 2017. We also examined reference lists of identified randomised controlled trials (RCTs) and systematic reviews, and contacted trial authors. </p> </section> <section id="CD011296-sec-0004"> <h3 class="title" id="CD011296-sec-0004">Selection criteria</h3> <p>We included RCTs comparing SSI with other strategies for glycaemic control in non‐critically ill hospitalised adult participants of any sex with diabetes mellitus. </p> </section> <section id="CD011296-sec-0005"> <h3 class="title" id="CD011296-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data, assessed trials for risk of bias, and evaluated the overall certainty of evidence utilising the GRADE instrument. We synthesised data using a random‐effects model meta‐analysis with 95% prediction intervals, if possible, or descriptive analysis, as appropriate. </p> </section> <section id="CD011296-sec-0006"> <h3 class="title" id="CD011296-sec-0006">Main results</h3> <p>Of 720 records screened, we included eight trials that randomised 1048 participants with type 2 diabetes (387 SSI participants and 615 participants in comparator groups were available for final analysis). We included non‐critically ill medical and surgical adults with the diagnosis of diabetes mellitus. The mean follow‐up time was measured by the mean length of hospital stay and ranged between five and 24 days. The mean age of participants was 44.5 years to 71 years. </p> <p>Overall, we judged the risk of bias on the trial level as unclear for selection bias, high for outcome‐related performance and detection bias with regard to hypoglycaemic episodes, other adverse events, and mean glucose levels, and low for all‐cause mortality and length of hospital stay. Attrition bias was low for all outcome measures. </p> <p>Six trials compared SSI with a basal‐bolus insulin scheme, three of which investigating 64% of all participants in this category also applying an SSI approach in the bolus comparator part. One trial had a basal insulin‐only comparator arm, and the remaining trial used continuous insulin infusion as the comparator. For our main comparison of SSI versus basal‐bolus insulin, the results were as follows. Four trials reported mortality data. One out of 268 participants in the SSI group (0.3%) compared with two out of 334 participants in the basal‐bolus group (0.6%) died (low‐certainty evidence). Severe hypoglycaemic episodes, defined as blood glucose levels below 40 mg/dL (2.2 mmol/L), showed a risk ratio (RR) of 0.22, 95% confidence interval (CI) 0.05 to 1.00; P = 0.05; 5 trials; 667 participants; very low‐certainty evidence. The 95% prediction interval ranged between 0.02 and 2.57. All nine severe hypoglycaemic episodes were observed among the 369 participants on basal‐bolus insulin (2.4%). The mean length of hospital stay was 0.5 days longer for the SSI group, 95% CI ‐0.5 to 1.4; P = 0.32; 6 trials; 717 participants; very low‐certainty evidence. The 95% prediction interval ranged between ‐1.7 days and 2.7 days. Adverse events other than hypoglycaemic episodes, such as postoperative infections, showed a RR of 1.16, 95% CI 0.25 to 5.37; P = 0.85; 3 trials; 481 participants; very low‐certainty evidence. The mean blood glucose levels ranged across basal‐bolus groups from 156 mg/dL (8.7 mmol/L) to 221 mg/dL (12.3 mmol/L). The mean blood glucose level in the SSI groups was 14.8 mg/dL (0.8 mmol/L) higher (95% CI 7.8 (0.4) to 21.8 (1.2); P &lt; 0.001; 6 trials; 717 participants; low‐certainty evidence). The 95% prediction interval ranged between ‐3.6 mg/dL (‐0.2 mmol/L) and 33.2 mg/dL (1.8 mmol/L). No trial reported on diabetes‐related mortality or socioeconomic effects. </p> </section> <section id="CD011296-sec-0007"> <h3 class="title" id="CD011296-sec-0007">Authors' conclusions</h3> <p>We are uncertain which insulin strategy (SSI or basal‐bolus insulin) is best for non‐critically hospitalised adults with diabetes mellitus. A basal‐bolus insulin strategy in these patients might result in better short‐term glycaemic control but could increase the risk for severe hypoglycaemic episodes. The certainty of the body of evidence comparing SSI with basal‐bolus insulin was low to very low and needs to be improved by adequately performed, well‐powered RCTs in different hospital environments with well‐educated medical staff using identical short‐acting insulins in both intervention and comparator arms to compare the rigid SSI approach with flexible insulin application strategies. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011296-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011296-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011296-abs-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011296-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011296-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011296-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011296-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011296-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011296-abs-0003" lang="en"> <h3>Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus</h3> <p><b>Review question</b> </p> <p>What are the effects of sliding scale insulin compared with other insulin therapies for non‐critically ill hospitalised adults with diabetes mellitus? </p> <p><b>Background</b> </p> <p>There are several options to treat people with diabetes who have been admitted to the hospital. Both low glucose levels (hypoglycaemia) and high glucose levels (hyperglycaemia) might increase the risk of death and complications such as infections and longer hospital stay and therefore should be avoided. The most common method to treat hospitalised people with diabetes is sliding scale insulin therapy. The term 'sliding scale' refers to the increasing administration of the pre‐meal insulin dose based on the blood sugar level before the meal. For example, if a person has a blood glucose level between 140 mg/dL to 180 mg/dL, a short‐acting usual insulin dose could be 4 units insulin, and for a blood glucose level between 181 mg/dL and 220 mg/dL, it could be 6 units insulin. This kind of rigid insulin application usually fixes the amount of carbohydrate to be eaten at each meal but does not deliver insulin in a physiologic manner. It is therefore doubtful whether good glycaemic control (satisfactory blood glucose levels) can be achieved by sliding scale insulin in hospitalised diabetic people and whether this approach results in better outcomes in the long term. There are other insulin strategies like background (basal) insulin doses combined with flexible pre‐meal insulin (bolus insulin) according to what and how much people want to eat. Sliding scale insulin means strict adherence to a regular schedule of meals and physical activity, and people must follow a prescribed diet. Intensified insulin therapy (basal‐bolus strategy) allows flexible insulin doses according to physical activity, stress, and meal preferences, and under hospital conditions demands well‐trained medical staff. Sliding scale insulin is still widely used, and it remains unclear which insulin strategy is best to treat hospitalised diabetic people. </p> <p><b>Study characteristics</b> </p> <p>We found eight randomised controlled trials (studies in which participants are assigned to one of two or more treatment groups in a random manner) where 387 people on sliding scale insulin therapy and 615 on mainly basal‐bolus insulin treatment with type 2 diabetes could be analysed. The average length of hospital stay was between five and 24 days. Six studies compared sliding scale insulin with basal‐bolus insulin; one study compared sliding scale insulin with basal insulin only; and the remaining study used continuous insulin infusion as the control group. The average age of participants was 44.5 years to 71 years. </p> <p>The evidence is up to date as of December 2017.</p> <p><b>Key results</b> </p> <p>The main comparison was between sliding scale insulin and basal‐bolus insulin therapy with the following results. Of the four studies reporting deaths, one out of 268 participants in the SSI group compared with two out of 334 participants in the basal‐bolus group died. Severe hypoglycaemic episodes, defined as blood glucose levels below 40 mg/dL, occurred in 5 per 1000 people in the sliding scale insulin groups compared with 24 per 1000 people in the basal‐bolus insulin groups. These data are uncertain because further analyses showed neither a positive nor a negative effect comparing both insulin strategies. The length of hospital stay in the sliding scale insulin groups compared with the basal‐bolus insulin groups was 0.5 days longer, again with further analyses indicating that this information is uncertain. The results for adverse events other than hypoglycaemic episodes, such as postoperative infections, did not indicate an advantage or disadvantage of either strategy. The average blood glucose level during hospital stay in the sliding scale groups was 14.8 mg/dL higher compared with the basal‐bolus groups. We are uncertain about these data because analyses showed neither a positive nor a negative effect comparing both insulin strategies. No trial reported on deaths caused by diabetes as such or socioeconomic effects like costs of the interventions or absence from work. </p> <p><b>Certainty of the evidence</b> </p> <p>Overall, our confidence in the results for all analysed outcomes was low or very low mainly due to the low number of studies and participants and because the results were not precise, that is they could change in any direction once new studies are published. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011296-sec-0117" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011296-sec-0117">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011296-sec-0198">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011296-sec-0117"></div> <h3 class="title" id="CD011296-sec-0118">Implications for practice</h3> <section id="CD011296-sec-0118"> <p>Based on low‐ to very low‐certainty evidence, our results for non‐critically ill hospitalised adults with diabetes mellitus in the medical and surgical in‐hospital setting showed that a basal‐bolus insulin strategy that applied higher total daily doses of insulin than the sliding scale insulin regimen might result in better short‐term glycaemic control but might also cause an increase in severe hypoglycaemic episodes. We are uncertain whether sliding scale insulin increases or decreases mortality, length of hospital stay, and adverse events other than hypoglycaemic episodes (such as infectious complications). </p> </section> <h3 class="title" id="CD011296-sec-0119">Implications for research</h3> <section id="CD011296-sec-0119"> <p>Future randomised controlled trials should adequately define the clinical conditions of hospitalised people with diabetes mellitus and the associated appropriate treatment choice. Multinational trials would improve the external validity of trial results. There is a need for adequately performed, well‐powered randomised controlled trials in different hospital environments with well‐educated medical staff. Identical short‐acting insulins in both intervention and comparator arms should be used to compare the rigid sliding scale insulin approach with flexible insulin application strategies. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011296-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011296-sec-0029"></div> <div class="table" id="CD011296-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Sliding scale insulin compared to basal‐bolus insulin for non‐critically ill hospitalised adults with diabetes mellitus</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Sliding scale insulin compared to basal‐bolus insulin for non‐critically ill hospitalised adults with diabetes mellitus</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> non‐critically ill hospitalised adults with diabetes mellitus<br/> <b>Setting:</b> medical and surgical inpatients<br/> <b>Intervention:</b> sliding scale insulin<br/> <b>Comparison:</b> basal‐bolus insulin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with basal‐bolus insulin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with sliding scale insulin</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No. of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality (N)</b> </p> <p>Follow‐up: 5 to 9 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>6 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 1000</b> (0 to 29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Peto OR 0.50 (0.05 to 4.85)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>602 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/8 trials reported data (very low number of events)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Diabetes‐related morbidity</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Severe hypoglycaemic episodes (N)</b> </p> <p>Follow‐up: 5 to 9 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>5 per 1000</b> (1 to 24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.22</b><br/> (0.05 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>667 (5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The 95% prediction interval ranged between 0.02 and 2.57</p> <p>All 9 severe hypoglycaemic episodes were observed among 369 participants (2.4%) in the basal‐bolus insulin groups </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Length of hospital stay (days)</b> </p> <p>Follow‐up: 5 to 24 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay ranged across control groups from 5.3 days to 24.2 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay in the intervention groups was <b>0.5 days longer</b> (0.5 days shorter to 1.4 days longer) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>717 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The 95% prediction interval ranged between ‐1.7 days and 2.7 days</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events other than hypoglycaemic episodes (postoperative complications, mainly infectious) (N)</b> </p> <p>Follow‐up: 6 to 24 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>62 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>72 per 1000</b> (15 to 332) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.16</b> (0.25 to 5.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>481 (3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean glucose level (mg/dL (mmol/L))</b> </p> <p>Follow‐up: 5 to 24 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean glucose level ranged across control groups from 156 mg/dL (8.7 mmol/L) to 221 mg/dL (12.3 mmol/L) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean glucose level in the intervention groups was <b>14.8 mg/dL (0.8 mmol/L) higher</b> (7.8 mg/dL (0.4 mmol/L) higher to 21.8 mg/dL (1.2 mmol/L) higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>717 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The 95% prediction interval ranged between ‐3.6 mg/dL (‐0.2 mmol/L) and 33.2 mg/dL (1.8 mmol/L) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Socioeconomic effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by two levels because of serious imprecision (small number of participants, small number of trials, uncommon event) (see <a href="./appendices#CD011296-sec-0136">Appendix 14</a>).<br/> <sup>b</sup>Downgraded by one level because of trial limitations (risk of performance and detection bias) and by two levels because of serious imprecision (small number of participants, confidence interval consistent with benefit and harm) (see <a href="./appendices#CD011296-sec-0136">Appendix 14</a>).<br/> <sup>c</sup>Downgraded by one level because of inconsistency (non‐consistent direction of effects) and by two levels because of serious imprecision (small median number of participants, confidence interval consistent with benefit and harm) (see <a href="./appendices#CD011296-sec-0136">Appendix 14</a>).<br/> <sup>d</sup>Downgraded by one level because of trial limitations (risk of performance and detection bias); by one level because of inconsistency (non‐consistent direction of effects); and by one level because of imprecision (small number of trials and participants, confidence interval consistent with benefit and harm) (see <a href="./appendices#CD011296-sec-0136">Appendix 14</a>).<br/> <sup>e</sup>Downgraded by one level because of trial limitations (risk of performance and detection bias) and by one level because of imprecision (small median number of participants) (see <a href="./appendices#CD011296-sec-0136">Appendix 14</a>). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011296-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011296-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011296-sec-0149">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD011296-sec-0030"></div> <section id="CD011296-sec-0031"> <h3 class="title" id="CD011296-sec-0031">Description of the condition</h3> <p>Diabetes mellitus (DM) is a metabolic disorder resulting from a defect in insulin secretion, function, or both. The consequence of DM is chronic hyperglycaemia, with subsequent effects on carbohydrate, fat, and protein metabolism. Long‐term DM complications include retinopathy, nephropathy, neuropathy, and an increased risk of cardiovascular disease (e.g. myocardial infarction, cerebrovascular events). Adequate glycaemic control in hospitalised people with DM represents a clinical challenge due to the wide range of treatment strategies and the morbidity/mortality risk that these participants present (<a href="./references#CD011296-bbs2-0079" title="UmpierrezGE , IsaacsSD , BazarganN , YouX , ThalerLM , KitabchiAE . Hyperglycemia: an independent marker of in‐hospital mortality in patients with undiagnosed diabetes. Journal of Clinical Endocrinology and Metabolism2002;87(3):978‐82. [DOI: 10.1210/jcem.87.3.8341; PUBMED: 11889147] ">Umpierrez 2002</a>). </p> <p>Diabetes mellitus is the most common chronic disease in low‐, middle‐, and high‐income countries. In 2000, the worldwide diabetes prevalence was 2.8% (for all age groups); in 2011, the global prevalence in the adult population was 8.3%. It is estimated that in 2030 diabetes prevalence will be 4.4% (for all age groups), affecting approximately 366 million people worldwide (<a href="./references#CD011296-bbs2-0082" title="WhitingDR , GuariguataL , WeilC , ShawJ . IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice2011;94(3):311‐21. [DOI: 10.1016/j.diabres.2011.10.029; PUBMED: 22079683] ">Whiting 2011</a>; <a href="./references#CD011296-bbs2-0084" title="WildS , RoglicG , GreenA , SicreeR , KingH . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care2004;27(5):1047‐53. [PUBMED: 15111519] ">Wild 2004</a>). </p> <p>People diagnosed with DM are frequently admitted for hospital care, with an estimated admission rate by year of about 25% to 30% (<a href="./references#CD011296-bbs2-0073" title="MossSE , KleinR , KleinBE . Risk factors for hospitalization in people with diabetes. Archives of Internal Medicine 199;159(17):2053‐7. [DOI: 10.1001/archinte.159.17.2053; PUBMED: 10510991] ">Moss 1999</a>). At hospital admission, glycaemic control becomes a priority; there is an expected increase in serum glucose because of the metabolic stress (caused by the present illness or procedures) resulting in hyperglycaemia, increased infection risk, and poor wound healing. Insulin therapy regimens are currently under discussion (<a href="./references#CD011296-bbs2-0048" title="BraithwaiteSS . Inpatient insulin therapy. Current Opinion in Endocrinology, Diabetes &amp; Obesity2008;15(2):159‐66. [DOI: 10.1097/MED.0b013e3282f827e7; PUBMED: 18316952] ">Braithwaite 2008</a>; <a href="./references#CD011296-bbs2-0050" title="BuchleitnerAM , Martínez‐AlonsoM , HernándezM , SolàI , MauricioD . Perioperative glycaemic control for diabetic patients undergoing surgery. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD007315.pub2] ">Buchleitner 2012</a>). Most of the data comes from people with critical care illness; however, even in these patients the best treatment regimens are unclear (<a href="./references#CD011296-bbs2-0053" title="FarrokhiF , KlindukhovaO , ChandraP , PengL , SmileyD , NewtonC , et al. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non‐critically ill patients with type 2 diabetes. Journal of Diabetes Science and Technology2012;6:1022‐9. ">Farrokhi 2012</a>; <a href="./references#CD011296-bbs2-0054" title="FriedrichJO , ChantC , AdhikariNK . Does intensive insulin therapy really reduce mortality in critically ill surgical patients? A reanalysis of meta‐analytic data. Critical Care2010;14(5):324. [DOI: 10.1186/cc9240; PUBMED: 21062514] ">Friedrich 2010</a>; <a href="./references#CD011296-bbs2-0056" title="GriesdaleDE , deSouzaRJ , vanDamRM , HeylandDK , CookDJ , MalhotraA , et al. Intensive insulin therapy and mortality among critically ill patients: a meta‐analysis including NICE‐SUGAR study data. Canadian Medical Association Journal2009;180(8):821‐7. [DOI: 10.1503/cmaj.090206; PUBMED: 19318387] ">Griesdale 2009</a>; <a href="./references#CD011296-bbs2-0066" title="KlonoffDC . Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective. Journal of Diabetes Science and Technology2011;5:755‐67. ">Klonoff 2011</a>). </p> </section> <section id="CD011296-sec-0032"> <h3 class="title" id="CD011296-sec-0032">Description of the intervention</h3> <p>Four strategies are used to achieve glycaemic control in hospitalised diabetic people: basal insulin, prandial insulin, correction‐dose insulin, and sliding scale insulin (SSI). These strategies are used to maintain optimal glucose levels (fasting and postprandial). The main difference between these strategies is the intervention purpose: basal insulin administration inhibits hepatic glucose production and is mainly responsible for controlling fasting glucose; prandial (bolus or mealtime) insulin aims to control postprandial glucose levels by promoting glucose disposal into the muscles; and correction dose insulin is administered in addition to prandial insulin using an algorithm‐based treatment to provide an adjustment to carbohydrate intake (<a href="./references#CD011296-bbs2-0068" title="LienLF , CoxME , FeinglosMN , CorsinoL . Glycemic control in the hospitalized patient. In: LienLF , CoxME , FeinglosMN , CorsinoL editor(s). Springer Science + Business Media, LLC. 2011. Vol. 1, New York: Springer New York, 2011:1‐145. [DOI: 10.1007/978‐1‐60761‐006‐9; 978‐1‐60761‐006‐9] ">Lien 2011</a>). </p> <p>Sliding scale insulin (sometimes called correctional insulin) is poorly defined and is used in different ways: traditionally, the insulin prescription is administered according to the measured blood glucose levels and therefore constitutes a reactive response to hyperglycaemia; SSI is an intervention usually characterised by a subcutaneous administration (regular insulin or rapid‐acting insulin analogues), regardless of the timing of food intake, presence or absence of pre‐existing insulin administration, and sensitivity to insulin, without the acute illness consideration. The SSI scheme aims to maintain the glucose levels between 7.7 mmol/L (140 mg/dL) and 10 mmol/L (180 mg/dL) (<a href="./references#CD011296-bbs2-0068" title="LienLF , CoxME , FeinglosMN , CorsinoL . Glycemic control in the hospitalized patient. In: LienLF , CoxME , FeinglosMN , CorsinoL editor(s). Springer Science + Business Media, LLC. 2011. Vol. 1, New York: Springer New York, 2011:1‐145. [DOI: 10.1007/978‐1‐60761‐006‐9; 978‐1‐60761‐006‐9] ">Lien 2011</a>; <a href="./references#CD011296-bbs2-0081" title="UmpierrezGE , HellmanR , KorytkowskiMT , KosiborodM , MaynardGA , MontoriVM , et al. Management of hyperglycemia in hospitalized patients in non‐critical care setting: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism2012;97(1):16‐38. [DOI: 10.1210/jc.2011‐2098; PUBMED: 22223765] ">Umpierrez 2012</a>). Some physicians even employ this approach using long‐acting insulin analogues or neutral protamine Hagedorn (NPH) insulin. </p> <p>Sliding scale insulin is regularly prescribed as part of the medical treatment in hospitalised diabetic people, despite the lack of physiological congruence and strong evidence to support it. </p> <section id="CD011296-sec-0033"> <h4 class="title">Adverse effects of the intervention</h4> <p>There are many considerations regarding the use of SSI in the treatment of diabetic inpatients. This strategy has been widely criticised when used to obtain glycaemic control. Previous studies have revealed longer days to achieve metabolic control, greater variability of glucose levels (hypoglycaemia and hyperglycaemia), higher infection rate, and increased mortality (<a href="./references#CD011296-bbs2-0044" title="BaldwinD , VillanuevaG , McNuttR , BhatnagarS . Eliminating inpatient sliding‐scale insulin: a reeducation project with medical house staff. Diabetes Care2005;28:1008‐11. [DOI: 10.2337/diacare.28.5.1008; PUBMED: 15855558] ">Baldwin 2005</a>; <a href="./references#CD011296-bbs2-0051" title="ChildsBP . Death to the sliding scale!. Diabetes Spectrum2003;16(2):68‐9. [DOI: 10.2337/diaspect.16.2.68] ">Childs 2003</a>; <a href="./references#CD011296-bbs2-0081" title="UmpierrezGE , HellmanR , KorytkowskiMT , KosiborodM , MaynardGA , MontoriVM , et al. Management of hyperglycemia in hospitalized patients in non‐critical care setting: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism2012;97(1):16‐38. [DOI: 10.1210/jc.2011‐2098; PUBMED: 22223765] ">Umpierrez 2012</a>). </p> </section> </section> <section id="CD011296-sec-0034"> <h3 class="title" id="CD011296-sec-0034">Why it is important to do this review</h3> <p>Sliding scale insulin is one of the most frequently used therapies in the metabolic control of diabetic inpatients. However, this strategy may be associated with poor glycaemic control causing more complications (higher infection rate, increased mortality, prolonged hospital stay). Several non‐systematic review articles have addressed the SSI scheme (<a href="./references#CD011296-bbs2-0072" title="MillerDB . Why won't the sliding scale go away?. Canadian Journal of Diabetes2011;35(4):340‐3. [DOI: 10.1016/S1499‐2671(11)54010‐9] ">Miller 2011</a>; <a href="./references#CD011296-bbs2-0080" title="UmpierrezGE , PalacioA , SmileyD . Sliding scale insulin use: myth or insanity?. American Journal of Medicine2007;120(7):563‐7. [DOI: 10.1016/j.amjmed.2006.05.070; PUBMED: 17602924] ">Umpierrez 2007b</a>). Given the potential public health relevance, we have systematically collected and examined all randomised controlled trials on SSI treatments for non‐critical diabetic hospitalised people in order to establish the risk and benefits of this therapy. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011296-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011296-sec-0035">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011296-sec-0154">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011296-sec-0035"></div> <p>To assess the effects of sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011296-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011296-sec-0036">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011296-sec-0155">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011296-sec-0036"></div> <section id="CD011296-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011296-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled clinical trials (RCTs).</p> </section> <section id="CD011296-sec-0039"> <h4 class="title">Types of participants</h4> <p>Non‐critically ill hospitalised adult (18 years or older) diabetic people. We expected that most of the trials would have type 2 diabetes participants, because people with type 1 diabetes mellitus require a basal‐bolus insulin treatment. We excluded nursing home residents and people treated in intensive care units. </p> <section id="CD011296-sec-0040"> <h5 class="title">Diagnostic criteria</h5> <p>In order to be consistent with changes in the classification of and diagnostic criteria for diabetes over the years, the diagnosis had to be established using the standard criteria valid at the time of the trial commencing (e.g. <a href="./references#CD011296-bbs2-0041" title="The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, the American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care1999;22(Suppl 1):S5‐19. ">ADA 1999</a>; <a href="./references#CD011296-bbs2-0042" title="American Diabetes Association. Standards of medical care in diabetes ‐ 2008. Diabetes Care2008;31(Suppl 1):S12‐54. [PUBMED: 18165335] ">ADA 2008</a>; <a href="./references#CD011296-bbs2-0083" title="AlbertiKM , ZimmetPZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine1998;15:539‐53. ">WHO 1998</a>). Ideally, the diagnostic criteria should have been described. Where necessary, we used the trial authors' definition of diabetes mellitus and planned to subject diagnostic criteria to a subgroup analysis. </p> </section> </section> <section id="CD011296-sec-0041"> <h4 class="title">Types of interventions</h4> <p>We planned to investigate the following comparisons of intervention versus comparator.</p> <section id="CD011296-sec-0042"> <h5 class="title">Intervention</h5> <p> <ul id="CD011296-list-0001"> <li> <p>Sliding scale insulin.</p> </li> </ul> </p> </section> <section id="CD011296-sec-0043"> <h5 class="title">Comparators</h5> <p> <ul id="CD011296-list-0002"> <li> <p>Basal insulin only.</p> </li> <li> <p>Basal‐bolus insulin (delivered by multiple subcutaneous injections or an insulin pump).</p> </li> <li> <p>Correction dose insulin.</p> </li> </ul> </p> <p>Other concomitant interventions had to be the same in the intervention and comparator groups to establish fair comparisons. </p> </section> <section id="CD011296-sec-0044"> <h5 class="title">Minimum duration of intervention and follow‐up</h5> <p>We accepted any duration of intervention and follow‐up.</p> <p>We defined extended follow‐up periods (also called open‐label extension studies) as follow up of participants once the original trial, as specified in the trial protocol, has been terminated. However, such studies are frequently of an observational nature, and we only planned to evaluate them for adverse events (<a href="./references#CD011296-bbs2-0049" title="BuchMH , AletahaD , EmeryP , SmolenJS . Reporting of long‐term extension studies: lack of consistency calls for consensus. Annals of the Rheumatic Diseases2011;70(6):886‐90. ">Buch 2011</a>; <a href="./references#CD011296-bbs2-0071" title="MeganB , PickeringRM , WeatherallM . Design, objectives, execution and reporting of published open‐label extension studies. Journal of Evaluation in Clinical Practice2012;18(2):209‐15. ">Megan 2012</a>). </p> </section> <section id="CD011296-sec-0045"> <h5 class="title">Summary of specific exclusion criteria</h5> <p> <ul id="CD011296-list-0003"> <li> <p>Nursing home residents and people treated in intensive care units.</p> </li> <li> <p>Children and adolescents up to 18 years of age.</p> </li> </ul> </p> <p>We did not exclude trials because one or several of our primary or secondary outcome measures were not reported in the publication. If no additional data were available, we planned to provide some basic information in a supplementary table. </p> </section> </section> <section id="CD011296-sec-0046"> <h4 class="title">Types of outcome measures</h4> <section id="CD011296-sec-0047"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD011296-list-0004"> <li> <p>All‐cause mortality.</p> </li> <li> <p>Diabetes‐related mortality.</p> </li> <li> <p>Hypoglycaemic episodes.</p> </li> </ul> </p> </section> <section id="CD011296-sec-0048"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD011296-list-0005"> <li> <p>Length of hospital stay.</p> </li> <li> <p>Adverse events other than hypoglycaemic episodes.</p> </li> <li> <p>Mean blood glucose.</p> </li> <li> <p>Socioeconomic effects.</p> </li> </ul> </p> <section id="CD011296-sec-0049"> <h6 class="title">Method and timing of outcome measurement</h6> <p> <ul id="CD011296-list-0006"> <li> <p>All‐cause mortality: defined as the total number of deaths from any cause, measured as in‐hospital mortality and as 30‐day all‐cause mortality. </p> </li> <li> <p>Diabetes‐related mortality: defined as the total number of deaths due to myocardial infarction, ischaemic heart disease, stroke or sequelae of stroke, heart failure, cardiac arrest, peripheral vascular disease, kidney disease, hyperglycaemia, and hypoglycaemia, measured as in‐hospital mortality and as 30‐day mortality. </p> </li> <li> <p>Hypoglycaemic episodes: defined as the number of blood glucose values less than 70 mg/dL or according to trial authors' definitions. </p> </li> <li> <p>Length of hospital stay: defined as the duration of a single episode of hospitalisation and measured by subtracting the day of admission from the day of discharge. </p> </li> <li> <p>Adverse events other than hypoglycaemia, e.g. hypokalaemia defined as a serum potassium concentration less than 3.5 mEq/L or injection site reactions, measured at any time during the hospital stay. </p> </li> <li> <p>Mean blood glucose: as measured during participant hospital stay.</p> </li> <li> <p>Socioeconomic effects, e.g. costs of the intervention, absence from work, medication consumption. </p> </li> </ul> </p> </section> </section> </section> </section> <section id="CD011296-sec-0050"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011296-sec-0051"> <h4 class="title">Electronic searches</h4> <p>We searched the following sources from the inception of each database to the date given, placing no restrictions on language of publication. </p> <p> <ul id="CD011296-list-0007"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) via the Cochrane Library (Issue 11 of 12, November 2017; searched on 22 December 2017). </p> </li> <li> <p>MEDLINE Ovid SP (Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE Daily and Ovid MEDLINE; 1946 to present; searched on 22 December 2017). </p> </li> <li> <p>Embase Ovid SP (1974 to 21 December 2017; searched on 22 December 2017).</p> </li> <li> <p>LILACS (Latin American and Caribbean Health Science Information database; last update 8 December 2017; searched on 22 December 2017). </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>) (searched on 22 December 2017). </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">www.who.int/trialsearch/</a>); searched on 22 December 2017). </p> </li> </ul> </p> <p>We applied a continuous MEDLINE (via Ovid SP) email alert service to identify newly published trials using the same search strategy as described for MEDLINE (<a href="./appendices#CD011296-sec-0123">Appendix 1</a>). </p> </section> <section id="CD011296-sec-0052"> <h4 class="title">Searching other resources</h4> <p>We attempted to identify other potentially eligible trials or ancillary publications by searching the reference lists of included trials, (systematic) reviews, meta‐analyses, and health technology assessment reports. </p> </section> </section> <section id="CD011296-sec-0053"> <h3 class="title" id="CD011296-sec-0053">Data collection and analysis</h3> <section id="CD011296-sec-0054"> <h4 class="title">Selection of studies</h4> <p>Two review authors (LECL, NDF) independently scanned the abstract, title, or both, of every record retrieved to determine which trials should be assessed further. We evaluated the full texts of all potentially relevant articles for inclusion in the review. Any discrepancies were resolved through consensus or by recourse to a third review author (AVH). We prepared a flow diagram of the number of trials identified and excluded at each stage in accordance with the PRISMA flow diagram of trial selection (<a href="./references#CD011296-bbs2-0067" title="LiberatiA , AltmanDG , TetzlaffJ , MulrowC , GøtzschePC , IoannidisJPA , et al. The PRISMA statement for reporting systematic and meta‐analyses of studies that evaluate interventions: explanation and elaboration. PLoS Medicine2009;6(7):1‐28. [DOI: 10.1371/journal.pmed.1000100] ">Liberati 2009</a>). </p> </section> <section id="CD011296-sec-0055"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (LECL, DGP) independently extracted key participant and intervention characteristics from the included trials. We reported data on efficacy outcomes and adverse events using standard data extraction forms from Cochrane Metabolic and Endocrine Disorders. Any disagreements were resolved by discussion or by consultation with a third review author (AVH) where necessary (for details see <a href="#CD011296-tbl-0002">Table 1</a>; <a href="./appendices#CD011296-sec-0124">Appendix 2</a>; <a href="./appendices#CD011296-sec-0125">Appendix 3</a>; <a href="./appendices#CD011296-sec-0126">Appendix 4</a>; <a href="./appendices#CD011296-sec-0127">Appendix 5</a>; <a href="./appendices#CD011296-sec-0128">Appendix 6</a>; <a href="./appendices#CD011296-sec-0129">Appendix 7</a>; <a href="./appendices#CD011296-sec-0130">Appendix 8</a>; <a href="./appendices#CD011296-sec-0131">Appendix 9</a>; <a href="./appendices#CD011296-sec-0132">Appendix 10</a>; <a href="./appendices#CD011296-sec-0133">Appendix 11</a>; <a href="./appendices#CD011296-sec-0134">Appendix 12</a>). </p> <div class="table" id="CD011296-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of trial populations</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial ID</b> </p> <p><b>(trial design)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Description of power and sample size calculation</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Screened/eligible<br/> (N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Randomised<br/> (N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Analysed<br/> (N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Finishing trial<br/> (N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Randomised finishing trial<br/> (%)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Follow‐up</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] "><b>Said 2013</b> </a> </p> <p><b>(parallel RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>‐/63</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>6 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C1: 70/30 insulin SSI (regular insulin + NPH)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C2: basal‐bolus regimen (glargine + glulisine)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>63</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>62</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>62</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>98</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. "><b>Umpierrez 2013</b> </a> </p> <p><b>(parallel non‐inferiority RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>"...reasonable to assume that the SD of mean daily BG is bounded by 50 mg/dL. On the basis of two‐sample t‐test or Wilcoxon test (one sided, α = 0.05), 147 subjects were required for both the basal plus and the basal‐bolus groups to ensure 80% power to reject the non‐inferiority hypothesis, with Bonferroni correction applied to adjust for multiple comparisons across four time points" </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>375 (210 medical and 165 surgical patients)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>6 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C1: basal‐bolus regimen (glargine once daily + glulisine before meals + corrective doses of glulisine by SSI) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>146<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C2: basal‐plus regimen (daily glargine + corrective doses of glulisine by SSI before meals) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>133</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>375<sup>b</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>353</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N/A</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] "><b>Schroeder 2012</b> </a> </p> <p><b>(cluster RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (short‐acting human insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>7 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: basal‐bolus regimen (NPH and regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>65</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>65</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>65</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>100</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] "><b>Umpierrez 2011</b> </a> </p> <p><b>(parallel RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"Assuming a within‐group standard deviation of 40 mg/dL and a‐error rate of 5% and a &lt;10% attrition rate, we estimated that 104 subjects per group were needed to achieve 90% power" </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1405/297</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>116</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>107</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>107</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>9 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: basal‐bolus regimen (glargine + glulisine)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>104</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>104</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>297/234<sup>c</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>211</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>211</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>90</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD011296-bbs2-0003" title="KorytkowskiMT , SalataRJ , KoerbelGL , SelzerF , KarsliogluE , IdrissAM , et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care2009;32(4):594‐6. [DOI: 10.2337/dc08‐1436] NCT00177398 . Effect of Glargine insulin on glucose control in hospitalized patients who receive tube feedings. clinicaltrials.gov/ct2/show/NCT00177398 (accessed 15 June 2018). "><b>Korytkowski 2009</b> </a> </p> <p><b>(parallel RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (regular insulin) + NPH for persistent glucose levels &gt; 10 mmol/L</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>24 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: basal‐bolus regimen (glargine + SSI regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>100</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] "><b>Umpierrez 2007a</b> </a> </p> <p><b>(parallel RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>130</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>5 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: basal‐bolus regimen (glargine + glulisine + SSI glulisine)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>130</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>130</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>130</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>100</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD011296-bbs2-0001" title="DattaS , QaadirA , VillanuevaG . Sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure. Endocrine Practice2007;13(3):225‐31. "><b>Datta 2007</b> </a> </p> <p><b>(parallel RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>81</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>5 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: basal regimen (glargine) + regular insulin if BG &gt; 200 mg/dL</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>81</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>81</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>81</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>100</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD011296-bbs2-0002" title="GustafsonPA , ZarroDL , PalanzoDA , ManleyNJ , MontesanoRM , QuinnM , et al. Conventional approach to glucose management for diabetic patients undergoing coronary artery bypass surgery. Perfusion2002;17(2):141‐4. [DOI: 10.1191/0267659102pf539oa] ">Gustafson 2002</a><b><sup>d</sup> </b> </p> <p><b>(parallel RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>1 day</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: continuous insulin infusion (regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>100</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b><i>Grand total</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All interventions</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>N/A</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>387</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="3" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All c</i> <i>omparators</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>N/A</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>615</i> </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All interventions and c</i> <i>omparators</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>1048</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>1002</i> </b> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>‐: denotes not reported</p> <p><sup>a</sup>According to table 1 (clinical characteristics of study patients) N = 144 participants.<br/> <sup>b</sup>22/375 (5.9%) participants were excluded from further analysis because they received &lt; 24 hours of insulin treatment, were transferred to the intensive care unit, or received corticosteroid therapy.<br/> <sup>c</sup>23/234 (9.8%) participants were excluded after randomisation because they received &lt; 24 hours of insulin treatment (N = 14); were treated with continuous insulin infusion during parenteral nutrition (N = 3); consent was withdrawn (N = 3); or surgery was cancelled (N = 3). 63/297 participants refused to participate at or after randomisation (information from trial flow diagram).<br/> <sup>d</sup>Participants were subdivided into two groups categorised by the type of cardioplegia administration and mode of insulin treatment. Group I participants received a 5% dextrose‐based cardioplegic solution and continuous insulin infusion for glucose management. Group II participants received normal saline‐based cardioplegia and sliding scale insulin for glucose management. </p> <p><b>BG</b> : blood glucose; <b>C</b> : comparator; <b>I</b> : intervention; <b>N/A</b> : not applicable; <b>NPH</b> : neutral protamine Hagedorn insulin; <b>RCT</b> : randomised controlled trial; <b>SD</b> : standard deviation; <b>SSI</b>: sliding scale insulin </p> </div> </div> <p>We provided information about potentially relevant ongoing trials, including trial identifier, in the <a href="./references#CD011296-sec-0148" title="">Characteristics of ongoing studies</a> table and in 'Matrix of study endpoints (publications and trial documents)' (<a href="./appendices#CD011296-sec-0128">Appendix 6</a>). We attempted to retrieve the protocol for each included trial and planned to report in <a href="./appendices#CD011296-sec-0128">Appendix 6</a> primary, secondary, and other outcomes in comparison with data in publications. </p> <p>We emailed the authors of all included trials to enquire as to whether they would be willing to answer questions regarding their trials. We presented the results of this survey in <a href="./appendices#CD011296-sec-0135">Appendix 13</a>. We sought relevant missing information on the trial from the primary author(s) of the article, if possible. </p> <section id="CD011296-sec-0056"> <h5 class="title">Dealing with duplicate and companion publications</h5> <p>In the event of duplicate publications, companion documents, or multiple reports of a primary trial, we maximised the information yield by collating all available data, and used the most complete data set aggregated across all known publications. We listed duplicate publications, companion documents, multiple reports of a primary trial, and trial documents of included trials (such as trial registry information) as secondary references under the study ID of the included trial. Furthermore, we listed duplicate publications, companion documents, multiple reports of a trial, and trial documents of excluded trials (such as trials registry information) as secondary references under the study ID of the excluded trial. </p> </section> <section id="CD011296-sec-0057"> <h5 class="title">Data from clinical trials registers</h5> <p>If data from included trials were available as study results in clinical trials registers such as ClinicalTrials.gov or similar sources, we made full use of this information and extracted the data. If there was also a full publication of the trial, we collated and critically appraised all available data. If an included trial was marked as a completed study in a clinical trials register but no additional information (study results, publication, or both) was available, we added this trial to the <a href="./references#CD011296-sec-0147" title="">Characteristics of studies awaiting classification</a> table. </p> </section> </section> <section id="CD011296-sec-0058"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (LECL, DGP) independently assessed the risk of bias of each included trial. Any disagreements were resolved by consensus or by consultation with a third review author (AVH) where necessary. If adequate information was unavailable from the trials, trial protocols, or both, we contacted the trial authors for missing data on 'Risk of bias' items. </p> <p>We used the Cochrane 'Risk of bias' assessment tool to assess each 'Risk of bias' domain as low, high, or unclear risk of bias as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (for details see <a href="./appendices#CD011296-sec-0124">Appendix 2</a>) (<a href="./references#CD011296-bbs2-0060" title="HigginsJPT , AltmanDG , GøtzschePC , JüniP , MoherD , OxmanAD , et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ2011;343:d5928. ">Higgins 2011a</a>; <a href="./references#CD011296-bbs2-0062" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available at www.training.cochrane.org/handbook. ">Higgins 2017</a>). </p> <section id="CD011296-sec-0059"> <h5 class="title">Summary assessment of risk of bias</h5> <p>We presented a 'Risk of bias' graph and a 'Risk of bias' summary figure.</p> <p>We distinguished between self reported, investigator assessed, and adjudicated outcome measures. </p> <p>We considered the following self reported outcomes.</p> <p> <ul id="CD011296-list-0008"> <li> <p>Adverse events other than hypoglycaemia.</p> </li> <li> <p>Hypoglycaemic episodes.</p> </li> </ul> </p> <p>We considered the following investigator‐assessed outcomes.</p> <p> <ul id="CD011296-list-0009"> <li> <p>Adverse events other than hypoglycaemia.</p> </li> <li> <p>All‐cause mortality.</p> </li> <li> <p>Diabetes‐related mortality.</p> </li> <li> <p>Hypoglycaemic episodes.</p> </li> <li> <p>Length of hospital stay.</p> </li> <li> <p>Mean blood glucose.</p> </li> <li> <p>Socioeconomic effects.</p> </li> </ul> </p> <section id="CD011296-sec-0060"> <h6 class="title">Risk of bias for a trial across outcomes</h6> <p>Some 'Risk of bias' domains such as selection bias (sequence generation and allocation sequence concealment) affect the risk of bias across all outcome measures in a trial. In case of high risk of selection bias, we marked all endpoints investigated in the associated trial as being at high risk. Otherwise, we did not performed a summary assessment of the risk of bias across all outcomes for a trial. </p> </section> <section id="CD011296-sec-0061"> <h6 class="title">Risk of bias for an outcome within a trial and across domains</h6> <p>We assessed the risk of bias for an outcome measure by including all entries relevant to that outcome (i.e. both trial‐level entries and outcome‐specific entries). We considered a judgement of low risk of bias to denote a low risk of bias for all key domains; unclear risk of bias to denote an unclear risk of bias for one or more key domains; and high risk of bias to denote a high risk of bias for one or more key domains. </p> </section> <section id="CD011296-sec-0062"> <h6 class="title">Risk of bias for an outcome across trials and across domains</h6> <p>These are the main summary assessments that we incorporated into our judgements about the certainty of evidence in the 'Summary of findings' tables. We defined outcomes as at low risk of bias when most information came from trials at low risk of bias; unclear risk of bias when most information came from trials at low or unclear risk of bias; and high risk of bias when a sufficient proportion of information came from trials at high risk of bias. </p> </section> </section> </section> <section id="CD011296-sec-0063"> <h4 class="title">Measures of treatment effect</h4> <p>When at least two trials were available for a comparison of a given outcome, we expressed dichotomous data as risk ratio (RR) with 95% confidence intervals (CIs). We planned to calculate time‐to‐event data as hazard ratio (HR) with 95% CI with the generic inverse variance method. We expressed continuous data reported on the same scale as mean difference (MD) with 95% CIs. For trials addressing the same outcome but using different outcome measure scales, we planned to use standardised mean differences (SMD) with 95% CI. </p> </section> <section id="CD011296-sec-0064"> <h4 class="title">Unit of analysis issues</h4> <p>We took into account the level at which randomisation occurred, such as cross‐over trials, cluster‐randomised trials, and multiple observations for the same outcome. If more than one comparison from the same trial was eligible for inclusion in the same meta‐analysis, we either combined groups to create a single, pairwise comparison, or we appropriately reduced the sample size so that the same participants did not contribute multiply times (splitting the 'shared' group into two or more groups). Although the latter approach offers some solution for adjusting the precision of the comparison, it does not account for correlation arising from inclusion of the same set of participants in multiple comparisons (<a href="./references#CD011296-bbs2-0061" title="HigginsJPT , DeeksJJ , Altman DG(editors) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). </p> <p>We planned to re‐analyse cluster‐randomised trials that did not appropriately adjust for potential clustering of participants in their analysis. Variance of the intervention effects would have been inflated by a design effect (DEFF). Calculation of a DEFF involves estimation of an intracluster correlation (ICC). We planned to obtain estimates of ICCs through contact with trial authors, or by imputing ICC values using either estimates from other included trials that reported ICCs or external estimates from empirical research (e.g. <a href="./references#CD011296-bbs2-0045" title="BellML , McKenzieJE . Designing psycho‐oncology randomised trials and cluster randomised trials: variance components and intra‐cluster correlation of commonly used psychosocial measures. Psycho‐Oncology2013;22:1738‐47. ">Bell 2013</a>). We planned to examine the impact of clustering by performing sensitivity analyses. </p> </section> <section id="CD011296-sec-0065"> <h4 class="title">Dealing with missing data</h4> <p>We attempted to obtain missing data from the authors of included trials. We carefully evaluated important numerical data such as screened, randomly assigned participants, as well as intention‐to‐treat and as‐treated and per‐protocol populations. We investigated attrition rates (e.g. dropouts, losses to follow‐up, withdrawals), and we critically appraised issues concerning missing data and imputation methods (e.g. last observation carried forward). </p> <p>When included trials did not report means and standard deviations for outcomes and we were unable to obtain the requested information from trial authors, we imputed these values by estimating the mean and the variance from the median, the range, and the size of the sample (<a href="./references#CD011296-bbs2-0063" title="HozoSP , DjulbegovicB , HozoI . Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology2005;5:13. [DOI: 10.1186/1471‐2288‐5‐13] ">Hozo 2005</a>). </p> <p>We planned to investigate the impact of imputation on meta‐analyses by performing sensitivity analyses. </p> </section> <section id="CD011296-sec-0066"> <h4 class="title">Assessment of heterogeneity</h4> <p>In the event of substantial clinical or methodological heterogeneity, we planned not to report trial results as the pooled effect estimate in a meta‐analysis. </p> <p>We identified heterogeneity (inconsistency) by visually inspecting the forest plots and by using a standard Chi² test with a significance level of α = 0.1 (<a href="./references#CD011296-bbs2-0052" title="DeeksJJ , HigginsJPT , Altman DG(editors) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available at www.training.cochrane.org/handbook. ">Deeks 2017</a>). In view of the low power of this test, we also considered the I² statistic, which quantifies inconsistency across trials, to assess the impact of heterogeneity on the meta‐analysis (<a href="./references#CD011296-bbs2-0057" title="HigginsJPT , ThompsonSG . Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine2002;21:1539‐58. ">Higgins 2002</a>; <a href="./references#CD011296-bbs2-0058" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analysis. BMJ2003;327:557‐60. ">Higgins 2003</a>). </p> </section> <section id="CD011296-sec-0067"> <h4 class="title">Assessment of reporting biases</h4> <p>If we included 10 or more trials investigating a particular outcome, we used funnel plots to assess small‐trial effects. Several explanations can account for funnel plot asymmetry, including true heterogeneity of effect with respect to trial size, poor methodological design (and hence bias of small trials), and publication bias (<a href="./references#CD011296-bbs2-0078" title="SterneJAC , EggerM , MoherD , BoutronI (editors) . Chapter 10: Addressing reporting biases. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available at www.training.cochrane.org/handbook. ">Sterne 2017</a>). We therefore interpreted results carefully (<a href="./references#CD011296-bbs2-0077" title="SterneJA , SuttonAJ , IoannidisJP , TerrinN , JonesDR , LauJ , et al. Recommendations for examining and interpreting funnel plot asymmetry in meta‐analyses of randomised controlled trials. BMJ2011;343:d4002. ">Sterne 2011</a>). </p> </section> <section id="CD011296-sec-0068"> <h4 class="title">Data synthesis</h4> <p>We planned to undertake (or display) a meta‐analysis only if we judged the participants, interventions, comparisons, and outcomes to be sufficiently similar to ensure an answer that would be clinically meaningful. Unless good evidence showed homogeneous effects across trials of different methodological quality, we primarily summarised data judged as at low risk of bias using a random‐effects model (<a href="./references#CD011296-bbs2-0086" title="WoodL , EggerM , GluudLL , SchulzKF , JuniP , AltmanDG , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ2008;336(7644):601‐5. ">Wood 2008</a>). We interpreted random‐effects meta‐analyses with due consideration for the whole distribution of effects and presented a 95% prediction interval (<a href="./references#CD011296-bbs2-0046" title="BorensteinM , HigginsJP , HedgesLV , RothsteinHR . Basics of meta‐analysis: I² is not an absolute measure of heterogeneity. Research Synthesis Methods2017;8(1):5‐18. ">Borenstein 2017a</a>; <a href="./references#CD011296-bbs2-0047" title="BorensteinM . Prediction intervals. www.meta‐analysis.com/prediction (accessed 3 July 2017). ">Borenstein 2017b</a>; <a href="./references#CD011296-bbs2-0059" title="HigginsJPT , ThompsonSG , SpiegelhalterDJ . A re‐evaluation of random‐effects meta‐analysis. Journal of the Royal Statistical Society: Series A (Statistics in Society)2009;172(1):137‐59. ">Higgins 2009</a>). A prediction interval requires at least three trials to be calculated and specifies a predicted range for the true treatment effect in an individual trial (<a href="./references#CD011296-bbs2-0075" title="RileyRD , HigginsJP , DeeksJJ . Interpretation of random effects meta‐analyses. BMJ2011;342:d549. ">Riley 2011</a>). For rare events such as event rates below 1%, we planned to use the Peto odds ratio (OR) method, provided there was no substantial imbalance between intervention and comparator group sizes, and intervention effects were not exceptionally large. In addition, we performed statistical analyses according to the statistical guidelines presented in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011296-bbs2-0052" title="DeeksJJ , HigginsJPT , Altman DG(editors) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available at www.training.cochrane.org/handbook. ">Deeks 2017</a>). </p> </section> <section id="CD011296-sec-0069"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We expected the following characteristics to introduce clinical heterogeneity and performed subgroup analyses to investigate interactions (<a href="./references#CD011296-bbs2-0043" title="AltmanDG , BlandJM . Interaction revisited: the difference between two estimates. BMJ2003;326(7382):219. [PUBMED: 12543843] ">Altman 2003</a>). </p> <p> <ul id="CD011296-list-0010"> <li> <p>Medical or surgical intervention.</p> </li> <li> <p>Comorbid conditions.</p> </li> <li> <p>Age, depending on data.</p> </li> <li> <p>Time of follow‐up.</p> </li> <li> <p>Type of insulin used.</p> </li> </ul> </p> </section> <section id="CD011296-sec-0070"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analyses to explore the influence of the following factors (when applicable) on effect sizes by restricting the analysis to the following. </p> <p> <ul id="CD011296-list-0011"> <li> <p>Published trials.</p> </li> <li> <p>Taking into account risk of bias, as specified in the <a href="#CD011296-sec-0058">Assessment of risk of bias in included studies</a> section. </p> </li> <li> <p>Use of the following filters: imputation, language of publication, source of funding (industry versus other), or country. </p> </li> </ul> </p> <p>We planned to test the robustness of results by repeating analysis using different measures of effect size (i.e. RR, OR, etc.) and different statistical models (fixed‐effect and random‐effects models). </p> <section id="CD011296-sec-0071"> <h5 class="title">Certainty of evidence</h5> <p>We presented the overall certainty of the evidence for each outcome specified below according to the GRADE approach, which takes into account issues related not only to internal validity (risk of bias, inconsistency, imprecision, publication bias) but also to external validity, such as directness of results<i>.</i> Two review authors (LECL, DGP) independently rated the certainty of evidence for each outcome. Differences in assessment were solved by discussion or by consultation with a third review author (AVH). </p> <p><a href="./appendices#CD011296-sec-0136">Appendix 14</a> 'Checklist to aid consistency and reproducibility of GRADE assessments' helps with standardisation of the 'Summary of findings' tables (<a href="./references#CD011296-bbs2-0070" title="MeaderN , KingK , LlewellynA , NormanG , BrownJ , RodgersM , et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Systematic Reviews2014;3:82. ">Meader 2014</a>). Alternatively, we planned to use GRADEpro GDT software and wanted to present evidence profile tables as an appendix (<a href="./references#CD011296-bbs2-0055" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 17 September 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT 2015</a>). We presented results for outcomes as described in the <a href="#CD011296-sec-0046">Types of outcome measures</a> section. If meta‐analysis was not possible, we presented the results in a narrative format in the 'Summary of findings' table. We justified all decisions to downgrade the certainty of the evidence with footnotes, and made comments to aid the reader's understanding where necessary. </p> <section id="CD011296-sec-0072"> <h6 class="title">'Summary of findings' table</h6> <p>We presented a summary of the evidence in the <a href="./full#CD011296-tbl-0001">summary of findings Table for the main comparison</a>. This provides key information about the best estimate of the magnitude of effect, in relative terms and as absolute differences for each relevant comparison of alternative management strategies, numbers of participants and trials addressing each important outcome, and a rating of overall confidence in effect estimates for each outcome. We created the <a href="./full#CD011296-tbl-0001">summary of findings Table for the main comparison</a> according to the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> and using the Review Manager 5 table editor (<a href="./references#CD011296-bbs2-0074" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>; <a href="./references#CD011296-bbs2-0076" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , AklE , et al. on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group. Chapter 11: Completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available at www.training.cochrane.org/handbook. ">Schünemann 2017</a>). We reported the following outcomes, listed according to priority. </p> <p> <ul id="CD011296-list-0012"> <li> <p>All‐cause mortality.</p> </li> <li> <p>Diabetes‐related mortality.</p> </li> <li> <p>Severe hypoglycaemic episodes.</p> </li> <li> <p>Length of hospital stay.</p> </li> <li> <p>Adverse events other than hypoglycaemia.</p> </li> <li> <p>Mean blood glucose.</p> </li> <li> <p>Socioeconomic effects.</p> </li> </ul> </p> </section> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011296-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011296-sec-0073"></div> <section id="CD011296-sec-0074"> <h3 class="title">Description of studies</h3> <p>For a detailed description of trials, see <a href="#CD011296-tbl-0002">Table 1</a> and <a href="./references#CD011296-sec-0145" title="">Characteristics of included studies</a>; <a href="./references#CD011296-sec-0146" title="">Characteristics of excluded studies</a>; <a href="./references#CD011296-sec-0147" title="">Characteristics of studies awaiting classification</a>; and <a href="./references#CD011296-sec-0148" title="">Characteristics of ongoing studies</a> sections. </p> <section id="CD011296-sec-0075"> <h4 class="title">Results of the search</h4> <p>The electronic search strategies retrieved a total of 939 articles. After exclusion of duplicates, two review authors (LECL, DGP) independently assessed 720 titles, abstracts, or both. We obtained the full text of 45 articles/records, of which eight completed trials were included in our review. One potentially relevant trial is ongoing (<a href="./references#CD011296-bbs2-0040" title="NCT01143948 . Various insulin regimens for diabetic inpatients with cirrhosis trial (VIRDICT). clinicaltrials.gov/ct2/show/NCT01143948 (accessed 1 February 2018). ">NCT01143948</a>), and two trials are awaiting classification (<a href="./references#CD011296-bbs2-0038" title="IRCT201311118307N2 . Basal/bolus versus sliding scale insulin in glycaemic control of diabetic patients with cardiovascular diseases. apps.who.int/trialsearch/Trial3.aspx?trialid=IRCT201311118307N2 (accessed 1 February 2018). ">IRCT201311118307N2</a>; <a href="./references#CD011296-bbs2-0039" title="ISRCTN55845280 . Intensive versus conventional insulin therapy for inpatient medical patients: a single centre randomized open trial [Insulinoterapia intensificada versus habitual en pacientes hospitalizador por patologia medica]. www.isrctn.com/ISRCTN55845280 (accessed 22 October 2018). ">ISRCTN55845280</a>) An adapted PRISMA flow diagram of trial selection is presented in <a href="#CD011296-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD011296-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Trial flow diagram." data-id="CD011296-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Trial flow diagram.</p> </div> </div> </div> </section> <section id="CD011296-sec-0076"> <h4 class="title">Included studies</h4> <p>For a detailed description of the characteristics of the included trials, see <a href="./references#CD011296-sec-0145" title="">Characteristics of included studies</a> and <a href="./appendices#CD011296-sec-0125">Appendix 3</a>; <a href="./appendices#CD011296-sec-0126">Appendix 4</a>; <a href="./appendices#CD011296-sec-0127">Appendix 5</a>; <a href="./appendices#CD011296-sec-0128">Appendix 6</a>; <a href="./appendices#CD011296-sec-0129">Appendix 7</a>; <a href="./appendices#CD011296-sec-0130">Appendix 8</a>; <a href="./appendices#CD011296-sec-0131">Appendix 9</a>; <a href="./appendices#CD011296-sec-0132">Appendix 10</a>; <a href="./appendices#CD011296-sec-0133">Appendix 11</a>; <a href="./appendices#CD011296-sec-0134">Appendix 12</a>). The following is a succinct overview. </p> <section id="CD011296-sec-0077"> <h5 class="title">Source of data</h5> <p>Eight trials met our inclusion criteria. These were published as peer‐reviewed articles in English. </p> </section> <section id="CD011296-sec-0078"> <h5 class="title">Comparisons</h5> <p>All included trials investigated SSI therapy against other strategies for glycaemic control. Six trials used a basal‐bolus regimen (<a href="./references#CD011296-bbs2-0003" title="KorytkowskiMT , SalataRJ , KoerbelGL , SelzerF , KarsliogluE , IdrissAM , et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care2009;32(4):594‐6. [DOI: 10.2337/dc08‐1436] NCT00177398 . Effect of Glargine insulin on glucose control in hospitalized patients who receive tube feedings. clinicaltrials.gov/ct2/show/NCT00177398 (accessed 15 June 2018). ">Korytkowski 2009</a>; <a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a>; <a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>; <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>; <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>; <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>). Two were three‐arm trials (<a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a>; <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>). <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a> also employed a basal‐bolus correction regimen, and <a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a> also used a mixed correction regimen (70/30 regular insulin plus neutral protamine Hagedorn (NPH) by means of SSI). One trial employed a basal insulin regimen by means of glargine plus regular insulin in 6% of cases (<a href="./references#CD011296-bbs2-0001" title="DattaS , QaadirA , VillanuevaG . Sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure. Endocrine Practice2007;13(3):225‐31. ">Datta 2007</a>), and another trial used a continuous insulin infusion strategy (<a href="./references#CD011296-bbs2-0002" title="GustafsonPA , ZarroDL , PalanzoDA , ManleyNJ , MontesanoRM , QuinnM , et al. Conventional approach to glucose management for diabetic patients undergoing coronary artery bypass surgery. Perfusion2002;17(2):141‐4. [DOI: 10.1191/0267659102pf539oa] ">Gustafson 2002</a>). </p> </section> <section id="CD011296-sec-0079"> <h5 class="title">Overview of trial population</h5> <p>A total of 1048 participants with type 2 diabetes were randomised to SSI intervention and comparators; 387 participants in the SSI groups and 615 in the comparator groups were finally analysed. The sample size of randomised individuals per trial ranged from 50 to 375 participants. </p> </section> <section id="CD011296-sec-0080"> <h5 class="title">Trial design</h5> <p>Seven trials had a parallel RCT design, and one trial was a cluster RCT (<a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>). The trials were published between 2002 and 2013. One trial was self funded (<a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a>), and five trials were partly or entirely sponsored by the pharmaceutical industry (<a href="./references#CD011296-bbs2-0001" title="DattaS , QaadirA , VillanuevaG . Sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure. Endocrine Practice2007;13(3):225‐31. ">Datta 2007</a>; <a href="./references#CD011296-bbs2-0003" title="KorytkowskiMT , SalataRJ , KoerbelGL , SelzerF , KarsliogluE , IdrissAM , et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care2009;32(4):594‐6. [DOI: 10.2337/dc08‐1436] NCT00177398 . Effect of Glargine insulin on glucose control in hospitalized patients who receive tube feedings. clinicaltrials.gov/ct2/show/NCT00177398 (accessed 15 June 2018). ">Korytkowski 2009</a>; <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>; <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>; <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>). </p> </section> <section id="CD011296-sec-0081"> <h5 class="title">Settings</h5> <p>Six trials were conducted in the USA (<a href="./references#CD011296-bbs2-0001" title="DattaS , QaadirA , VillanuevaG . Sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure. Endocrine Practice2007;13(3):225‐31. ">Datta 2007</a>; <a href="./references#CD011296-bbs2-0002" title="GustafsonPA , ZarroDL , PalanzoDA , ManleyNJ , MontesanoRM , QuinnM , et al. Conventional approach to glucose management for diabetic patients undergoing coronary artery bypass surgery. Perfusion2002;17(2):141‐4. [DOI: 10.1191/0267659102pf539oa] ">Gustafson 2002</a>; <a href="./references#CD011296-bbs2-0003" title="KorytkowskiMT , SalataRJ , KoerbelGL , SelzerF , KarsliogluE , IdrissAM , et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care2009;32(4):594‐6. [DOI: 10.2337/dc08‐1436] NCT00177398 . Effect of Glargine insulin on glucose control in hospitalized patients who receive tube feedings. clinicaltrials.gov/ct2/show/NCT00177398 (accessed 15 June 2018). ">Korytkowski 2009</a>; <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>; <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>; <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>), one trial in Israel (<a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>), and one in Egypt (<a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a>). Four trials evaluated surgical participants (<a href="./references#CD011296-bbs2-0001" title="DattaS , QaadirA , VillanuevaG . Sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure. Endocrine Practice2007;13(3):225‐31. ">Datta 2007</a>; <a href="./references#CD011296-bbs2-0002" title="GustafsonPA , ZarroDL , PalanzoDA , ManleyNJ , MontesanoRM , QuinnM , et al. Conventional approach to glucose management for diabetic patients undergoing coronary artery bypass surgery. Perfusion2002;17(2):141‐4. [DOI: 10.1191/0267659102pf539oa] ">Gustafson 2002</a>; <a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>; <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>); three trials evaluated medical inpatients (<a href="./references#CD011296-bbs2-0003" title="KorytkowskiMT , SalataRJ , KoerbelGL , SelzerF , KarsliogluE , IdrissAM , et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care2009;32(4):594‐6. [DOI: 10.2337/dc08‐1436] NCT00177398 . Effect of Glargine insulin on glucose control in hospitalized patients who receive tube feedings. clinicaltrials.gov/ct2/show/NCT00177398 (accessed 15 June 2018). ">Korytkowski 2009</a>; <a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a>; <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>); and one trial evaluated both surgical and medical participants (<a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>). </p> </section> <section id="CD011296-sec-0082"> <h5 class="title">Participants</h5> <p>Two trials specified the ethnic background of their participants (<a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>; <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>). Two trials reported the duration of diabetes mellitus (<a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>; <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>). The percentage of female participants per intervention/comparator group ranged between 26% and 86%. The mean age of participants ranged between 44.5 years and 71 years. The mean participants' glycated haemoglobin ranged between 7.4% and 8.9%. The mean body mass index (BMI) ranged between 26.9 kg/m² and 55 kg/m². Major exclusion criteria within the included trials were no history of diabetes, type 1 DM, corticosteroid therapy during hospitalisation, hyperglycaemic crisis, admission to an intensive care unit, severe heart failure or cardiogenic shock, clinically relevant hepatic disease, impaired renal function, gastrointestinal bleeding, pregnancy, inability to give informed consent, and any mental condition. </p> </section> <section id="CD011296-sec-0083"> <h5 class="title">Interventions</h5> <p>The average daily insulin dose of SSI ranged between 8 units and 28 units. The average daily dose of basal‐bolus insulin ranged between 12 units and 44 units, and the average daily dose of basal‐plus insulin was 27 units. The mean duration of hospital stay ranged between 5 and 24 days. </p> </section> <section id="CD011296-sec-0084"> <h5 class="title">Outcomes</h5> <p>Five trials explicitly stated a primary endpoint in the publication (<a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a>; <a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>; <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>; <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>; <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>). The most commonly defined primary outcomes in the publications were differences in glycaemic control, as measured by mean daily blood glucose concentration. Five trials were registered in ClinicalTrials.gov (<a href="./references#CD011296-bbs2-0003" title="KorytkowskiMT , SalataRJ , KoerbelGL , SelzerF , KarsliogluE , IdrissAM , et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care2009;32(4):594‐6. [DOI: 10.2337/dc08‐1436] NCT00177398 . Effect of Glargine insulin on glucose control in hospitalized patients who receive tube feedings. clinicaltrials.gov/ct2/show/NCT00177398 (accessed 15 June 2018). ">Korytkowski 2009</a>; <a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a>; <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>; <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>; <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>). </p> </section> </section> <section id="CD011296-sec-0085"> <h4 class="title">Excluded studies</h4> <p>We excluded 29 of 45 articles/records after evaluation of the full publication/record. The main reasons for exclusion were wrong trial design, wrong population, wrong setting, and wrong comparison (for further details see <a href="./references#CD011296-sec-0146" title="">Characteristics of excluded studies</a>). </p> </section> </section> <section id="CD011296-sec-0086"> <h3 class="title">Risk of bias in included studies</h3> <p>For an overview of review authors' judgements about each 'Risk of bias' item for individual trials and across all trials, see <a href="#CD011296-fig-0002">Figure 2</a> and <a href="#CD011296-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD011296-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials (blank cells indicate that the particular outcome was not investigated in some trials)." data-id="CD011296-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials (blank cells indicate that the particular outcome was not investigated in some trials). </p> </div> </div> </div> <div class="figure" id="CD011296-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included trial (blank cells indicate that the trial did not report that particular outcome)." data-id="CD011296-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included trial (blank cells indicate that the trial did not report that particular outcome). </p> </div> </div> </div> <section id="CD011296-sec-0087"> <h4 class="title">Allocation</h4> <p>Two trials had a low risk of selection bias (<a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>; <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>), and six trials did not provide enough information to adequately judge selection bias (<a href="./references#CD011296-bbs2-0001" title="DattaS , QaadirA , VillanuevaG . Sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure. Endocrine Practice2007;13(3):225‐31. ">Datta 2007</a>; <a href="./references#CD011296-bbs2-0002" title="GustafsonPA , ZarroDL , PalanzoDA , ManleyNJ , MontesanoRM , QuinnM , et al. Conventional approach to glucose management for diabetic patients undergoing coronary artery bypass surgery. Perfusion2002;17(2):141‐4. [DOI: 10.1191/0267659102pf539oa] ">Gustafson 2002</a>; <a href="./references#CD011296-bbs2-0003" title="KorytkowskiMT , SalataRJ , KoerbelGL , SelzerF , KarsliogluE , IdrissAM , et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care2009;32(4):594‐6. [DOI: 10.2337/dc08‐1436] NCT00177398 . Effect of Glargine insulin on glucose control in hospitalized patients who receive tube feedings. clinicaltrials.gov/ct2/show/NCT00177398 (accessed 15 June 2018). ">Korytkowski 2009</a>; <a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a>; <a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>; <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>). </p> </section> <section id="CD011296-sec-0088"> <h4 class="title">Blinding</h4> <p>The majority of trials showed a high risk of performance and detection bias for the outcome measures hypoglycaemic episodes, adverse events other than hypoglycaemic episodes, and mean glucose levels. </p> </section> <section id="CD011296-sec-0089"> <h4 class="title">Incomplete outcome data</h4> <p>We rated all trials as at low risk of attrition bias if all data for the associated outcome measures were reported. <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a> excluded 10% of randomised participants from the analysis, and <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a> excluded 6% of randomised participants from the analysis (for details see <a href="#CD011296-tbl-0002">Table 1</a>). </p> </section> <section id="CD011296-sec-0090"> <h4 class="title">Selective reporting</h4> <p>We rated one trial as at high risk of reporting bias (<a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>). </p> </section> <section id="CD011296-sec-0091"> <h4 class="title">Other potential sources of bias</h4> <p>We rated one trial as at unclear risk of other bias because it did not use adequate statistical analyses for its cluster‐randomised design (<a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>). </p> </section> </section> <section id="CD011296-sec-0092"> <h3 class="title" id="CD011296-sec-0092">Effects of interventions</h3> <p>See: <a href="./full#CD011296-tbl-0001"><b>Summary of findings for the main comparison</b> Sliding scale insulin compared to basal‐bolus insulin for non‐critically ill hospitalised adults with diabetes mellitus</a> </p> <p>Most trials compared an SSI regimen with a basal‐bolus insulin regimen (<a href="./references#CD011296-bbs2-0003" title="KorytkowskiMT , SalataRJ , KoerbelGL , SelzerF , KarsliogluE , IdrissAM , et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care2009;32(4):594‐6. [DOI: 10.2337/dc08‐1436] NCT00177398 . Effect of Glargine insulin on glucose control in hospitalized patients who receive tube feedings. clinicaltrials.gov/ct2/show/NCT00177398 (accessed 15 June 2018). ">Korytkowski 2009</a>; <a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a>; <a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>; <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>; <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>; <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>). Three of these trials, investigating 64% of all participants for this comparison, also applied the SSI approach in the bolus comparator part (<a href="./references#CD011296-bbs2-0003" title="KorytkowskiMT , SalataRJ , KoerbelGL , SelzerF , KarsliogluE , IdrissAM , et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care2009;32(4):594‐6. [DOI: 10.2337/dc08‐1436] NCT00177398 . Effect of Glargine insulin on glucose control in hospitalized patients who receive tube feedings. clinicaltrials.gov/ct2/show/NCT00177398 (accessed 15 June 2018). ">Korytkowski 2009</a>; <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>; <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>), thus essentially reducing the comparison to the evaluation of additional basal insulin administration. <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a> had a second comparator arm ("basal‐plus"), which did not differ in a clinically relevant way from the basal‐bolus arm of the trial. We used only the results of the basal‐bolus comparator part of this trial in our review. </p> <section id="CD011296-sec-0093"> <h4 class="title">Baseline characteristics</h4> <p>For details of baseline characteristics, see <a href="./appendices#CD011296-sec-0126">Appendix 4</a> and <a href="./appendices#CD011296-sec-0127">Appendix 5</a>. </p> </section> <section id="CD011296-sec-0094"> <h4 class="title">SSI versus basal‐bolus insulin</h4> <section id="CD011296-sec-0095"> <h5 class="title">Primary outcomes</h5> <section id="CD011296-sec-0096"> <h6 class="title">All‐cause mortality</h6> <p>Four trials reported data on death (<a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a>; <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>; <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>; <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>). One of 268 participants in the SSI group (0.3%) compared with two of 334 participants in the basal‐bolus group (0.6%) died (Peto odds ratio 0.50, 95% confidence interval (CI) 0.05 to 4.85; 4 trials; 602 participants; low‐certainty evidence; <a href="./references#CD011296-fig-0004" title="">Analysis 1.1</a>). </p> </section> <section id="CD011296-sec-0097"> <h6 class="title">Diabetes‐related mortality</h6> <p>No trial reported on diabetes‐related mortality.</p> </section> <section id="CD011296-sec-0098"> <h6 class="title">Hypoglycaemic episodes</h6> <section id="CD011296-sec-0099"> <p><b>Non‐severe hypoglycaemia</b></p> <p>Non‐severe hypoglycaemia was usually defined by trial authors as a blood glucose level below 60 mg/dL (3.3 mmol/L) or 70 mg/dL (3.9 mmol/L). <a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a> reported that "no significant difference was noted in hypoglycaemic rates (blood glucose level below 70 mg/dL) between the two groups (P = 0.6)". <a href="./references#CD011296-bbs2-0003" title="KorytkowskiMT , SalataRJ , KoerbelGL , SelzerF , KarsliogluE , IdrissAM , et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care2009;32(4):594‐6. [DOI: 10.2337/dc08‐1436] NCT00177398 . Effect of Glargine insulin on glucose control in hospitalized patients who receive tube feedings. clinicaltrials.gov/ct2/show/NCT00177398 (accessed 15 June 2018). ">Korytkowski 2009</a> reported hypoglycaemia frequency as the percentage of patient‐days with one or more event (SSI compared with basal‐bolus insulin: 4.8 days versus 2.7 days, with P = 0.34) and percentage of all glucose values less than 3.9 mmol/L (70 mg/dL) (SSI compared with basal‐bolus insulin: 1.1 blood glucose measures versus 1.3 blood glucose measures, P = 0.35). </p> <p>The risk ratio (RR) for non‐severe hypoglycaemic episodes comparing SSI with basal‐bolus insulin was 0.25 (95% CI 0.11 to 0.59 in favour of SSI; P = 0.001; 3 trials; 561 participants; <a href="./references#CD011296-fig-0005" title="">Analysis 1.2</a>). Overall, nine non‐severe hypoglycaemic episodes occurred in 246 participants on SSI (3.7%) compared with 49 non‐severe hypoglycaemic episodes in 315 participants on basal‐bolus insulin (15.6%). Calculation of the 95% prediction interval did not reveal a meaningful interval. Performance bias and detection bias were high in the majority of the included trials reporting this outcome. </p> <p>Comparing the subgroup of medical with surgical inpatients did not show a statistically significant interaction effect of subgroup differences. There were not enough data to analyse the other prespecified subgroups. </p> </section> <section id="CD011296-sec-0100"> <p><b>Severe hypoglycaemia</b></p> <p>Five trials reported on severe hypoglycaemic episodes (<a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a>; <a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>; <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>; <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>; <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>). Severe hypoglycaemia was defined by trial authors as blood glucose levels below 40 mg/dL (2.2 mmol/L), <a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a>; <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>; <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>; <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>, or as hypoglycaemia requiring intravenous glucose administration (<a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>). The RR for severe hypoglycaemic episodes comparing SSI with basal‐bolus insulin was 0.22 (95% CI 0.05 to 1.00; P = 0.05; 5 trials; 667 participants; very low‐certainty evidence; <a href="./references#CD011296-fig-0006" title="">Analysis 1.3</a>). All nine severe hypoglycaemic episodes were observed among the 369 participants on basal‐bolus insulin (2.4%). The 95% prediction interval ranged between 0.02 and 2.57. The fixed‐effect model showed a RR of 0.20 (95% CI 0.05 to 0.87). Elimination of the cluster RCT, <a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>, showed a statistically non‐significant effect estimate for both the random‐effects and the fixed‐effect model (RR 0.22, 95% CI 0.04 to 1.24 and RR 0.20, 95% CI 0.04 to 1.03, respectively). Performance bias and detection bias were high in the majority of the included trials reporting this outcome. </p> </section> </section> </section> <section id="CD011296-sec-0101"> <h5 class="title">Secondary outcomes</h5> <section id="CD011296-sec-0102"> <h6 class="title">Length of hospital stay</h6> <p>Six trials reported data on length of hospital stay (<a href="./references#CD011296-bbs2-0003" title="KorytkowskiMT , SalataRJ , KoerbelGL , SelzerF , KarsliogluE , IdrissAM , et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care2009;32(4):594‐6. [DOI: 10.2337/dc08‐1436] NCT00177398 . Effect of Glargine insulin on glucose control in hospitalized patients who receive tube feedings. clinicaltrials.gov/ct2/show/NCT00177398 (accessed 15 June 2018). ">Korytkowski 2009</a>; <a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a>; <a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>; <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>; <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>; <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>). The mean length of hospital stay ranged across basal‐bolus groups from 5.3 days to 24.2 days. The mean length of hospital stay in the SSI groups was 0.5 days longer (95% CI ‐0.5 to 1.4; P = 0.32; 6 trials; 717 participants; very low‐certainty evidence; <a href="./references#CD011296-fig-0007" title="">Analysis 1.4</a>). The 95% prediction interval ranged between ‐1.7 days and 2.7 days. Elimination of the cluster RCT, <a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>, showed a mean difference between intervention and comparator groups of ‐0.06 days (95% CI ‐0.91 to 0.80). </p> <p>Comparing the subgroup of medical with surgical inpatients did not show a statistically significant interaction effect of subgroup differences. There were not enough data to analyse the other prespecified subgroups. </p> </section> <section id="CD011296-sec-0103"> <h6 class="title">Adverse events other than hypoglycaemic episodes (such as postoperative infections)</h6> <p>Four trials reported on adverse events other than hypoglycaemic episodes (<a href="./references#CD011296-bbs2-0003" title="KorytkowskiMT , SalataRJ , KoerbelGL , SelzerF , KarsliogluE , IdrissAM , et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care2009;32(4):594‐6. [DOI: 10.2337/dc08‐1436] NCT00177398 . Effect of Glargine insulin on glucose control in hospitalized patients who receive tube feedings. clinicaltrials.gov/ct2/show/NCT00177398 (accessed 15 June 2018). ">Korytkowski 2009</a>; <a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>; <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a><a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>). </p> <p><a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a> reported that "there was no difference in the postoperative complications between the groups. No difference in operative‐related and unrelated complications between groups was noted". </p> <p>The RR for postoperative complications comparing SSI with basal‐bolus insulin was 1.16 (95% CI 0.25 to 5.37; P = 0.85; 3 trials; 481 participants; very low‐certainty evidence; <a href="./references#CD011296-fig-0008" title="">Analysis 1.5</a>). Overall, 20 complications among 206 participants on SSI (9.7%) occurred compared with 17 complications among 275 participants on basal‐bolus insulin (6.2%). Calculation of the 95% prediction interval did not reveal a meaningful interval. Performance bias and detection bias were high in the majority of the included trials reporting this outcome, and selection bias was high for <a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>. </p> </section> <section id="CD011296-sec-0104"> <h6 class="title">Mean blood glucose levels</h6> <p>Six trials reported on mean glucose level during hospital stay (<a href="./references#CD011296-bbs2-0003" title="KorytkowskiMT , SalataRJ , KoerbelGL , SelzerF , KarsliogluE , IdrissAM , et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care2009;32(4):594‐6. [DOI: 10.2337/dc08‐1436] NCT00177398 . Effect of Glargine insulin on glucose control in hospitalized patients who receive tube feedings. clinicaltrials.gov/ct2/show/NCT00177398 (accessed 15 June 2018). ">Korytkowski 2009</a>; <a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a>; <a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>; <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>; <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>; <a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. ">Umpierrez 2013</a>). The mean blood glucose level ranged across basal‐bolus groups from 156 mg/dL (8.7 mmol/L) to 221 mg/dL (12.3 mmol/L). The mean blood glucose level in the SSI groups was 14.8 mg/dL (0.8 mmol/L) higher (95% CI 7.8 (0.4) to 21.8 (1.2); P &lt; 0.001; 6 trials; 717 participants; low‐certainty evidence; <a href="./references#CD011296-fig-0009" title="">Analysis 1.6</a>). The 95% prediction interval ranged between ‐3.6 mg/dL (‐0.2 mmol/L) and 33.2 mg/dL (1.8 mmol/L). The cluster RCT, <a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] ">Schroeder 2012</a>, did not have a substantial impact on the effect size (data not shown). </p> <p>Comparing the subgroup of medical with surgical inpatients did not show a statistically significant interaction effect of subgroup differences. There were not enough data to analyse the other prespecified subgroups. </p> <p>Four trials reported on hyperglycaemia, which was variably defined (<a href="./references#CD011296-bbs2-0001" title="DattaS , QaadirA , VillanuevaG . Sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure. Endocrine Practice2007;13(3):225‐31. ">Datta 2007</a>; <a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a>; <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a>; <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>). <a href="./references#CD011296-bbs2-0001" title="DattaS , QaadirA , VillanuevaG . Sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure. Endocrine Practice2007;13(3):225‐31. ">Datta 2007</a> reported that 16% of SSI‐treated participants compared with 6% of basal‐bolus insulin‐treated participants had blood glucose levels greater than 200 mg/dL. <a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] ">Said 2013</a> reported that 68% of SSI‐treated participants compared to 53% of basal‐bolus insulin‐treated participants had blood glucose levels greater than 300 mg/dL. Blood glucose levels greater than 240 mg/dL were reported in 9% of SSI‐treated participants in <a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] ">Umpierrez 2007a</a> and in 12% of SSI‐treated participants in <a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] ">Umpierrez 2011</a>. </p> <p>All trials reported that the mean total daily dose of insulin in the basal‐bolus group was greater than in the SSI group. </p> </section> <section id="CD011296-sec-0105"> <h6 class="title">Socioeconomic effects</h6> <p>No trial reported on socioeconomic effects.</p> </section> </section> </section> <section id="CD011296-sec-0106"> <h4 class="title">SSI versus basal insulin</h4> <p>Only one trial compared an SSI regimen with a basal insulin regimen (<a href="./references#CD011296-bbs2-0001" title="DattaS , QaadirA , VillanuevaG . Sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure. Endocrine Practice2007;13(3):225‐31. ">Datta 2007</a>). This trial, which involved 81 participants, did not provide information on all‐cause mortality, diabetes‐related mortality, or socioeconomic effects. One of 39 participants in the SSI group (2.6%) compared with two of 42 participants in the basal insulin group (4.8%) reported a non‐severe hypoglycaemic episode (<a href="./references#CD011296-fig-0010" title="">Analysis 2.1</a>). Mean length of hospital stay was the same in both the intervention and the comparator group (3.8 days; <a href="./references#CD011296-fig-0011" title="">Analysis 2.2</a>). Adverse events other than hypoglycaemic episodes (postoperative infections) were reported in two participants in both the intervention and the comparator group (<a href="./references#CD011296-fig-0012" title="">Analysis 2.3</a>). The mean blood glucose level in the SSI group was 20 mg/dL higher than in the basal insulin group (<a href="./references#CD011296-fig-0013" title="">Analysis 2.4</a>). </p> <p>One trial compared SSI with a continuous insulin infusion during coronary artery bypass surgery in 50 participants (<a href="./references#CD011296-bbs2-0002" title="GustafsonPA , ZarroDL , PalanzoDA , ManleyNJ , MontesanoRM , QuinnM , et al. Conventional approach to glucose management for diabetic patients undergoing coronary artery bypass surgery. Perfusion2002;17(2):141‐4. [DOI: 10.1191/0267659102pf539oa] ">Gustafson 2002</a>). The only outcome measure of relevance for this review was mean blood glucose levels, which were 110 mg/dL less in the post‐cardiopulmonary bypass period in the SSI group compared with the continuous insulin infusion group (<a href="./references#CD011296-fig-0014" title="">Analysis 3.1</a>). There was also a difference in the cardioplegic solution between the groups: the continuous insulin infusion group received a dextrose 5%‐based cardioplegic solution, and the SSI group received normal 0.9% saline, limiting the interpretation of the results of this trial. </p> </section> <section id="CD011296-sec-0107"> <h4 class="title">Subgroup analyses</h4> <p>With the exception of medical versus surgical inpatients for some outcome measures, we did not perform subgroup analyses as data were insufficient to estimate effects in various subgroups. </p> </section> <section id="CD011296-sec-0108"> <h4 class="title">Sensitivity analyses</h4> <p>With the exception of comparing the random‐effects model with the fixed‐effect model for some outcome measures, we did not perform sensitivity analyses due to insufficient data. </p> </section> <section id="CD011296-sec-0109"> <h4 class="title">Assessment of reporting bias</h4> <p>We did not draw funnel plots due to the limited number of trials (N = 8).</p> </section> <section id="CD011296-sec-0110"> <h4 class="title">Ongoing studies</h4> <p>We found one ongoing trial, <a href="./references#CD011296-bbs2-0040" title="NCT01143948 . Various insulin regimens for diabetic inpatients with cirrhosis trial (VIRDICT). clinicaltrials.gov/ct2/show/NCT01143948 (accessed 1 February 2018). ">NCT01143948</a>, and two trials awaiting classification, <a href="./references#CD011296-bbs2-0038" title="IRCT201311118307N2 . Basal/bolus versus sliding scale insulin in glycaemic control of diabetic patients with cardiovascular diseases. apps.who.int/trialsearch/Trial3.aspx?trialid=IRCT201311118307N2 (accessed 1 February 2018). ">IRCT201311118307N2</a>; <a href="./references#CD011296-bbs2-0039" title="ISRCTN55845280 . Intensive versus conventional insulin therapy for inpatient medical patients: a single centre randomized open trial [Insulinoterapia intensificada versus habitual en pacientes hospitalizador por patologia medica]. www.isrctn.com/ISRCTN55845280 (accessed 22 October 2018). ">ISRCTN55845280</a> (for details see <a href="./references#CD011296-sec-0148" title="">Characteristics of ongoing studies</a> and <a href="./references#CD011296-sec-0147" title="">Characteristics of studies awaiting classification</a> sections). </p> <p>The ongoing trial is investigating an SSI regimen compared with a basal‐bolus insulin regimen in approximately 45 participants with type 2 diabetes and liver cirrhosis. </p> <p>Two trials awaiting classification, with a total of approximately 320 participants, compared an SSI regimen with a basal‐bolus insulin regimen in diabetic people with cardiovascular diseases and diabetic people with acute medical and surgical conditions. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011296-sec-0111" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011296-sec-0111">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011296-sec-0192">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011296-sec-0111"></div> <section id="CD011296-sec-0112"> <h3 class="title" id="CD011296-sec-0112">Summary of main results</h3> <p>This systematic review analysed the evidence from published RCTs of SSI therapy for the treatment of non‐critically ill adults with diabetes mellitus. We included eight trials randomising 1048 participants with type 2 diabetes. The main comparison with SSI was basal‐bolus insulin therapy. A basal‐bolus insulin strategy might result in better short‐term glycaemic control, but might also result in an increase in severe hypoglycaemic episodes. We are uncertain about the effects of SSI and basal‐bolus insulin on length of hospital stay, postoperative complications, and mean blood glucose levels. No studies reported on diabetes‐related mortality or socioeconomic effects. </p> </section> <section id="CD011296-sec-0113"> <h3 class="title" id="CD011296-sec-0113">Overall completeness and applicability of evidence</h3> <p>Most trials analysed in our review were conducted in the USA, and younger adult diabetic participants were underrepresented in the trials. Our inclusion criteria specified surgical and medical patients, and both were represented, reflecting the general practice in the non‐critical hospital environment. However, most trials did not include people with newly diagnosed diabetes, people who were treated with insulin before hospitalisation, or people on corticosteroid therapy, who all form an important part of the hospitalised population with hyperglycaemia. The total daily dose of insulin was lower in the SSI groups compared with the basal‐bolus insulin groups, probably reflecting that the SSI regimen on admission remained unchanged throughout the hospitalisation period. It is therefore unclear whether the results of this review are associated with the SSI regimen per se or a suboptimal insulin dosing in the SSI intervention groups, which might be an attribute of the rigid SSI treatment approach. </p> </section> <section id="CD011296-sec-0114"> <h3 class="title" id="CD011296-sec-0114">Quality of the evidence</h3> <p>We assessed the certainty of the evidence as low to very low mainly because of trial limitations (especially performance bias and detection bias), imprecision (low number of participants and trials, wide prediction intervals), and inconsistency (non‐consistent direction of effects) for most of the outcome measures. </p> </section> <section id="CD011296-sec-0115"> <h3 class="title" id="CD011296-sec-0115">Potential biases in the review process</h3> <p>We attempted to contact the trial authors to obtain additional information (<a href="./appendices#CD011296-sec-0135">Appendix 13</a>), as well as information about potential admissions of non‐critically ill participants to intensive care units, but did not receive an answer from the authors of three included trials. We therefore cannot exclude the possibility that in some trials some participants were also treated in critical care. Furthermore, we did not systematically search the grey literature. </p> </section> <section id="CD011296-sec-0116"> <h3 class="title" id="CD011296-sec-0116">Agreements and disagreements with other studies or reviews</h3> <p>Lee 2015 published a meta‐analysis of SSI treatment for blood glucose control. The review authors included 11 trials in their meta‐analysis but did not discriminate between critical and non‐critical care participants. <a href="./references#CD011296-bbs2-0019" title="Gómez CuervoC , Sánchez MorlaA , Pérez‐Jacoiste AsínMA , Bisbal PardoO , Pérez OrdoñoL , Vila SantosJ . Effective adverse event reduction with bolus‐basal versus sliding scale insulin therapy in patients with diabetes during conventional hospitalization: systematic review and meta‐analysis. Endocrinologia y Nutricion2016;63(4):145‐56. ">Gómez Cuervo 2016</a> published a meta‐analysis of adverse events related to basal‐bolus insulin therapy compared with SSI. The review authors included five trials combining observational studies and RCTs in their meta‐analysis. <a href="./references#CD011296-bbs2-0012" title="ChristensenMB , GotfredsenA , NørgaardK . Efficacy of basal‐bolus insulin regimens in the inpatient management of non‐critically ill patients with type 2 diabetes: a systematic review and meta‐analysis. Diabetes/Metabolism Research and Reviews2017;33:e2885. [DOI: 10.1002/dmrr.2885] ">Christensen 2017</a> published a meta‐analysis of basal‐bolus insulin regimens compared to other insulin regimens. The review authors included five trials using basal‐bolus insulin as the main intervention in their meta‐analysis. The overall results of these reviews were similar to our results, indicating that SSI therapy resulted in lower hypoglycaemia rates and higher mean glucose levels compared with non‐SSI therapies. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011296-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/urn:x-wiley:14651858:media:CD011296:CD011296-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_t/tCD011296-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Trial flow diagram." data-id="CD011296-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Trial flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/full#CD011296-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011296-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/urn:x-wiley:14651858:media:CD011296:CD011296-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_t/tCD011296-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials (blank cells indicate that the particular outcome was not investigated in some trials)." data-id="CD011296-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials (blank cells indicate that the particular outcome was not investigated in some trials). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/full#CD011296-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011296-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/urn:x-wiley:14651858:media:CD011296:CD011296-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_t/tCD011296-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included trial (blank cells indicate that the trial did not report that particular outcome)." data-id="CD011296-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included trial (blank cells indicate that the trial did not report that particular outcome). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/full#CD011296-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011296-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/urn:x-wiley:14651858:media:CD011296:CD011296-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_t/tCD011296-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sliding scale insulin versus basal‐bolus insulin regimen, Outcome 1 All‐cause mortality." data-id="CD011296-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Sliding scale insulin versus basal‐bolus insulin regimen, Outcome 1 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#CD011296-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011296-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/urn:x-wiley:14651858:media:CD011296:CD011296-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_t/tCD011296-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sliding scale insulin versus basal‐bolus insulin regimen, Outcome 2 Non‐severe hypoglycaemic episodes." data-id="CD011296-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Sliding scale insulin versus basal‐bolus insulin regimen, Outcome 2 Non‐severe hypoglycaemic episodes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#CD011296-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011296-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/urn:x-wiley:14651858:media:CD011296:CD011296-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_t/tCD011296-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sliding scale insulin versus basal‐bolus insulin regimen, Outcome 3 Severe hypoglycaemic episodes." data-id="CD011296-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Sliding scale insulin versus basal‐bolus insulin regimen, Outcome 3 Severe hypoglycaemic episodes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#CD011296-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011296-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/urn:x-wiley:14651858:media:CD011296:CD011296-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_t/tCD011296-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sliding scale insulin versus basal‐bolus insulin regimen, Outcome 4 Length of hospital stay." data-id="CD011296-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Sliding scale insulin versus basal‐bolus insulin regimen, Outcome 4 Length of hospital stay. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#CD011296-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011296-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/urn:x-wiley:14651858:media:CD011296:CD011296-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_t/tCD011296-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sliding scale insulin versus basal‐bolus insulin regimen, Outcome 5 Adverse events other than hypoglycaemic episodes (infectious complications)." data-id="CD011296-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Sliding scale insulin versus basal‐bolus insulin regimen, Outcome 5 Adverse events other than hypoglycaemic episodes (infectious complications). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#CD011296-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011296-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/urn:x-wiley:14651858:media:CD011296:CD011296-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_t/tCD011296-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Sliding scale insulin versus basal‐bolus insulin regimen, Outcome 6 Mean glucose levels." data-id="CD011296-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Sliding scale insulin versus basal‐bolus insulin regimen, Outcome 6 Mean glucose levels. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#CD011296-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011296-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/urn:x-wiley:14651858:media:CD011296:CD011296-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_t/tCD011296-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sliding scale insulin versus basal insulin regimen, Outcome 1 Non‐severe hypoglycaemic episodes." data-id="CD011296-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Sliding scale insulin versus basal insulin regimen, Outcome 1 Non‐severe hypoglycaemic episodes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#CD011296-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011296-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/urn:x-wiley:14651858:media:CD011296:CD011296-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_t/tCD011296-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sliding scale insulin versus basal insulin regimen, Outcome 2 Length of hospital stay." data-id="CD011296-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Sliding scale insulin versus basal insulin regimen, Outcome 2 Length of hospital stay. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#CD011296-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011296-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/urn:x-wiley:14651858:media:CD011296:CD011296-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_t/tCD011296-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sliding scale insulin versus basal insulin regimen, Outcome 3 Adverse events other than hypoglycaemic episodes." data-id="CD011296-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Sliding scale insulin versus basal insulin regimen, Outcome 3 Adverse events other than hypoglycaemic episodes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#CD011296-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011296-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/urn:x-wiley:14651858:media:CD011296:CD011296-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_t/tCD011296-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sliding scale insulin versus basal insulin regimen, Outcome 4 Mean glucose levels." data-id="CD011296-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Sliding scale insulin versus basal insulin regimen, Outcome 4 Mean glucose levels. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#CD011296-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011296-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/urn:x-wiley:14651858:media:CD011296:CD011296-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_t/tCD011296-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Sliding scale insulin versus continuous insulin infusion, Outcome 1 Mean glucose levels." data-id="CD011296-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Sliding scale insulin versus continuous insulin infusion, Outcome 1 Mean glucose levels. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#CD011296-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/media/CDSR/CD011296/image_n/nCD011296-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011296-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Sliding scale insulin compared to basal‐bolus insulin for non‐critically ill hospitalised adults with diabetes mellitus</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Sliding scale insulin compared to basal‐bolus insulin for non‐critically ill hospitalised adults with diabetes mellitus</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> non‐critically ill hospitalised adults with diabetes mellitus<br/> <b>Setting:</b> medical and surgical inpatients<br/> <b>Intervention:</b> sliding scale insulin<br/> <b>Comparison:</b> basal‐bolus insulin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with basal‐bolus insulin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with sliding scale insulin</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No. of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality (N)</b> </p> <p>Follow‐up: 5 to 9 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>6 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 1000</b> (0 to 29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Peto OR 0.50 (0.05 to 4.85)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>602 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/8 trials reported data (very low number of events)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Diabetes‐related morbidity</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Severe hypoglycaemic episodes (N)</b> </p> <p>Follow‐up: 5 to 9 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>5 per 1000</b> (1 to 24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.22</b><br/> (0.05 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>667 (5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The 95% prediction interval ranged between 0.02 and 2.57</p> <p>All 9 severe hypoglycaemic episodes were observed among 369 participants (2.4%) in the basal‐bolus insulin groups </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Length of hospital stay (days)</b> </p> <p>Follow‐up: 5 to 24 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay ranged across control groups from 5.3 days to 24.2 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay in the intervention groups was <b>0.5 days longer</b> (0.5 days shorter to 1.4 days longer) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>717 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The 95% prediction interval ranged between ‐1.7 days and 2.7 days</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events other than hypoglycaemic episodes (postoperative complications, mainly infectious) (N)</b> </p> <p>Follow‐up: 6 to 24 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>62 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>72 per 1000</b> (15 to 332) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.16</b> (0.25 to 5.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>481 (3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean glucose level (mg/dL (mmol/L))</b> </p> <p>Follow‐up: 5 to 24 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean glucose level ranged across control groups from 156 mg/dL (8.7 mmol/L) to 221 mg/dL (12.3 mmol/L) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean glucose level in the intervention groups was <b>14.8 mg/dL (0.8 mmol/L) higher</b> (7.8 mg/dL (0.4 mmol/L) higher to 21.8 mg/dL (1.2 mmol/L) higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>717 (6)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The 95% prediction interval ranged between ‐3.6 mg/dL (‐0.2 mmol/L) and 33.2 mg/dL (1.8 mmol/L) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Socioeconomic effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by two levels because of serious imprecision (small number of participants, small number of trials, uncommon event) (see <a href="./appendices#CD011296-sec-0136">Appendix 14</a>).<br/> <sup>b</sup>Downgraded by one level because of trial limitations (risk of performance and detection bias) and by two levels because of serious imprecision (small number of participants, confidence interval consistent with benefit and harm) (see <a href="./appendices#CD011296-sec-0136">Appendix 14</a>).<br/> <sup>c</sup>Downgraded by one level because of inconsistency (non‐consistent direction of effects) and by two levels because of serious imprecision (small median number of participants, confidence interval consistent with benefit and harm) (see <a href="./appendices#CD011296-sec-0136">Appendix 14</a>).<br/> <sup>d</sup>Downgraded by one level because of trial limitations (risk of performance and detection bias); by one level because of inconsistency (non‐consistent direction of effects); and by one level because of imprecision (small number of trials and participants, confidence interval consistent with benefit and harm) (see <a href="./appendices#CD011296-sec-0136">Appendix 14</a>).<br/> <sup>e</sup>Downgraded by one level because of trial limitations (risk of performance and detection bias) and by one level because of imprecision (small median number of participants) (see <a href="./appendices#CD011296-sec-0136">Appendix 14</a>). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Sliding scale insulin compared to basal‐bolus insulin for non‐critically ill hospitalised adults with diabetes mellitus</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/full#CD011296-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011296-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of trial populations</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial ID</b> </p> <p><b>(trial design)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Description of power and sample size calculation</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Screened/eligible<br/> (N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Randomised<br/> (N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Analysed<br/> (N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Finishing trial<br/> (N)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Randomised finishing trial<br/> (%)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Follow‐up</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><a href="./references#CD011296-bbs2-0004" title="NCT01855243 . Comparison on efficacy and safety of three inpatient insulin therapy in type2 DM. clinicaltrials.gov/ct2/show/NCT01855243 (accessed 15 June 2018). SaidE , FaridS , SabryN , FawziM . Comparison on efficacy and safety of three inpatient insulin regimens for management of non‐critical patients with type 2 diabetes. Pharmacology &amp; Pharmacy2013;4:556‐65. [DOI: 10.4236/pp.2013.47080] "><b>Said 2013</b> </a> </p> <p><b>(parallel RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>‐/63</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>6 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C1: 70/30 insulin SSI (regular insulin + NPH)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C2: basal‐bolus regimen (glargine + glulisine)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>63</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>62</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>62</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>98</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><a href="./references#CD011296-bbs2-0008" title="NCT00979628 . Basal bolus versus basal insulin in type 2 diabetes mellitus (T2DM) (Basal‐Plus). clinicaltrials.gov/ct2/show/NCT00979628 (accessed 15 June 2018). UmpierrezGE , SmileyD , HermayerK , KhanA , OlsonDE , NewtonC , et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care2013;36:2169–74. "><b>Umpierrez 2013</b> </a> </p> <p><b>(parallel non‐inferiority RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>"...reasonable to assume that the SD of mean daily BG is bounded by 50 mg/dL. On the basis of two‐sample t‐test or Wilcoxon test (one sided, α = 0.05), 147 subjects were required for both the basal plus and the basal‐bolus groups to ensure 80% power to reject the non‐inferiority hypothesis, with Bonferroni correction applied to adjust for multiple comparisons across four time points" </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>375 (210 medical and 165 surgical patients)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>6 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C1: basal‐bolus regimen (glargine once daily + glulisine before meals + corrective doses of glulisine by SSI) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>146<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C2: basal‐plus regimen (daily glargine + corrective doses of glulisine by SSI before meals) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>133</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>375<sup>b</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>353</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N/A</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD011296-bbs2-0005" title="SchroederJE , LiebergallM , RazI , EglestonR , Ben SussanG , PeyserA , et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes/Metabolism Research and Reviews2012;28(1):71‐5. [DOI: 10.1002/dmrr.1217] "><b>Schroeder 2012</b> </a> </p> <p><b>(cluster RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (short‐acting human insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>7 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: basal‐bolus regimen (NPH and regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>65</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>65</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>65</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>100</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD011296-bbs2-0007" title="NCT00596687 . Basal bolus insulin versus SSRI in type 2 diabetes undergoing general surgery (RABBIT 2‐SX). clinicaltrials.gov/ct2/show/NCT00596687 (accessed 15 June 2018). UmpierrezGE , SmileyD , JacobsS , PengL , TemponiA , MulliganP , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care2011;34(2):256‐61. [DOI: 10.2337/dc10‐1407] "><b>Umpierrez 2011</b> </a> </p> <p><b>(parallel RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>"Assuming a within‐group standard deviation of 40 mg/dL and a‐error rate of 5% and a &lt;10% attrition rate, we estimated that 104 subjects per group were needed to achieve 90% power" </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1405/297</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>116</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>107</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>107</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>9 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: basal‐bolus regimen (glargine + glulisine)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>104</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>104</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>297/234<sup>c</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>211</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>211</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>90</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD011296-bbs2-0003" title="KorytkowskiMT , SalataRJ , KoerbelGL , SelzerF , KarsliogluE , IdrissAM , et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care2009;32(4):594‐6. [DOI: 10.2337/dc08‐1436] NCT00177398 . Effect of Glargine insulin on glucose control in hospitalized patients who receive tube feedings. clinicaltrials.gov/ct2/show/NCT00177398 (accessed 15 June 2018). "><b>Korytkowski 2009</b> </a> </p> <p><b>(parallel RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (regular insulin) + NPH for persistent glucose levels &gt; 10 mmol/L</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>24 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: basal‐bolus regimen (glargine + SSI regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>100</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD011296-bbs2-0006" title="NCT00394407 . Basal/bolus versus sliding scale insulin in hospitalized patients with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00394407 (accessed 15 June 2018). UmpierrezGE , SmileyD , ZismanA , PrietoLM , PalacioA , CeronM , et al. Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care2007;30(9):2181‐6. [DOI: 10.2337/dc07‐0295] "><b>Umpierrez 2007a</b> </a> </p> <p><b>(parallel RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>130</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>5 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: basal‐bolus regimen (glargine + glulisine + SSI glulisine)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>130</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>130</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>130</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>100</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD011296-bbs2-0001" title="DattaS , QaadirA , VillanuevaG . Sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure. Endocrine Practice2007;13(3):225‐31. "><b>Datta 2007</b> </a> </p> <p><b>(parallel RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>81</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>5 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: basal regimen (glargine) + regular insulin if BG &gt; 200 mg/dL</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>81</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>81</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>81</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>100</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD011296-bbs2-0002" title="GustafsonPA , ZarroDL , PalanzoDA , ManleyNJ , MontesanoRM , QuinnM , et al. Conventional approach to glucose management for diabetic patients undergoing coronary artery bypass surgery. Perfusion2002;17(2):141‐4. [DOI: 10.1191/0267659102pf539oa] ">Gustafson 2002</a><b><sup>d</sup> </b> </p> <p><b>(parallel RCT)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: SSI (regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>1 day</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: continuous insulin infusion (regular insulin)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>50</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>100</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b><i>Grand total</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All interventions</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>N/A</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>387</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="3" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All c</i> <i>omparators</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>N/A</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>615</i> </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All interventions and c</i> <i>omparators</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>1048</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>1002</i> </b> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>‐: denotes not reported</p> <p><sup>a</sup>According to table 1 (clinical characteristics of study patients) N = 144 participants.<br/> <sup>b</sup>22/375 (5.9%) participants were excluded from further analysis because they received &lt; 24 hours of insulin treatment, were transferred to the intensive care unit, or received corticosteroid therapy.<br/> <sup>c</sup>23/234 (9.8%) participants were excluded after randomisation because they received &lt; 24 hours of insulin treatment (N = 14); were treated with continuous insulin infusion during parenteral nutrition (N = 3); consent was withdrawn (N = 3); or surgery was cancelled (N = 3). 63/297 participants refused to participate at or after randomisation (information from trial flow diagram).<br/> <sup>d</sup>Participants were subdivided into two groups categorised by the type of cardioplegia administration and mode of insulin treatment. Group I participants received a 5% dextrose‐based cardioplegic solution and continuous insulin infusion for glucose management. Group II participants received normal saline‐based cardioplegia and sliding scale insulin for glucose management. </p> <p><b>BG</b> : blood glucose; <b>C</b> : comparator; <b>I</b> : intervention; <b>N/A</b> : not applicable; <b>NPH</b> : neutral protamine Hagedorn insulin; <b>RCT</b> : randomised controlled trial; <b>SD</b> : standard deviation; <b>SSI</b>: sliding scale insulin </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of trial populations</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/full#CD011296-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011296-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Sliding scale insulin versus basal‐bolus insulin regimen</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>602</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.05, 4.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Non‐severe hypoglycaemic episodes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>561</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.11, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Medical participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.15, 6.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Surgical participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.08, 0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Medical/surgical participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.04, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Severe hypoglycaemic episodes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>667</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.05, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>717</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [‐0.46, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Medical participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [‐0.94, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Surgical participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [‐0.97, 3.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Medical/surgical participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐1.80, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Adverse events other than hypoglycaemic episodes (infectious complications) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>481</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.25, 5.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mean glucose levels <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>717</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>14.79 [7.75, 21.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Medical participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.52 [‐14.38, 33.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Surgical participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.20 [9.95, 22.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Medical/surgical participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.0 [4.98, 27.02]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Sliding scale insulin versus basal‐bolus insulin regimen</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#CD011296-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011296-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sliding scale insulin versus basal insulin regimen</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Non‐severe hypoglycaemic episodes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse events other than hypoglycaemic episodes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mean glucose levels <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sliding scale insulin versus basal insulin regimen</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#CD011296-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011296-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Sliding scale insulin versus continuous insulin infusion</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean glucose levels <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Sliding scale insulin versus continuous insulin infusion</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011296.pub2/references#CD011296-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011296.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011296-note-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011296-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011296-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD011296-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD011296-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011296-note-0012">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011296\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011296\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011296\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011296\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011296\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011296.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011296.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011296.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011296.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011296.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729605227"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011296.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729605231"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011296.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ee0e9df299377',t:'MTc0MDcyOTYwNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 